Adult Medicine Ambulatory Care Cardiology Central Nervous System Clinical Administration Critical Care Drug Information

Education and Training Emergency Medicine Endocrine and Metabolism Geriatrics GI/Liver/Nutrition Hematology/Oncology Immunology/Transplantation

Infectious Diseases Nephrology Pain and Palliative Care Pediatrics Pharmaceutical Industry PK/PD/PG Women’s Health

Introduction:

The Adult Medicine PRN consists of practitioners, residents, and students who share an interest in shaping the practice of adult medicine through research and practice in a variety of settings. The following paragraphs highlight some of the Adult Medicine PRN’s activities and member accomplishments.

Looking toward the ACCP Annual Meeting this fall, the Adult Medicine PRN Programming Committee has been actively planning a focus session highlighting the optimal use of dual antiplatelet therapy. Practitioners will have the opportunity to review current evidence regarding indications for antiplatelet therapy and strategies for preventing complications from treatment.

The PRN Archives Committee has been developing revised online content and ensuring that the content and format are best suited for our members. Our Training and Travel Awards Committee continues to award students and new practitioners with travel awards for the 2014 ACCP Annual Meeting. The Nominations Committee has also reviewed applications and presented two awards to exceptional members this year. These recipients were recognized at the PRN’s business meeting last fall. Details can be found below.

 

Promotions:

Diane Rhee, Pharm.D.: Received a promotion to associate professor of pharmacy practice.

Elizabeth Sebranek Evans, Pharm.D., BCPS, CGP: Received a promotion to associate professor of pharmacy practice.

 

Awards:

Donald F. Brophy, Pharm.D., M.Sc., FCCP, FASN, BCPS: Received the Adult Medicine PRN Distinguished Investigator Award, October 2013.

Rachel Flurie, Pharm.D.: Received the Adult Medicine PRN Resident Travel Award.

David Lourwood, Pharm.D.: Received the Adult Medicine PRN Practitioner Registration Award.

Joel C. Marrs, Pharm.D., BCPS (AQ Cardiology), CLS: Received the Adult Medicine PRN Award for Clinical Practice, October 2013.

Alexandra C. Vance, Pharm.D., BCPS: Received the Navy Civilian Pharmacist of the Year Award, November 2013.

Rebecca Wolfe, Pharm.D. Candidate: Received the Adult Medicine PRN Student Travel Award.

 

Grants:

Melissa Butler, Pharm.D., BCPS, MPH:

Atlanta Clinical and Translational Science Institute – Pilot Grants: Using a Holistic Approach to Understand Medication Adherence in Hypertension.

 

Iain O. Buxton, Pharm.D., FAHA:

Awarded grants as PI/coinvestigator: Post-translational S-Nitrosation of Therapeutic Targets in Pregnancy and Labor. CTR NIH 1U54GM104944-01. Integrin Regulation of Stretch-Activated Myometrial Signaling During Pregnancy and Labor. NIH HD067342. Genetic Basis for a New Spontaneous Preterm Labor Treatment. UNR Foundation.

Awarded grants as mentor: Cell Biology of Signaling Across Membranes. NIH 8P20GM103554-02 (Von Bartheld PI/Buxton Mentor, Project 3; Dagda).

Pending grants: The Role of TREK-1 in Uterine Quiescence Signaling. NIH K99/Roo. PI Chad L. Cowles, Mentor Buxton. Post-translational S-nitrosation of Therapeutic Targets in Human Pregnancy, Labor and Preterm Labor. NIH R01.

 

Publications:

Alotaibi GS, Almodaimegh H, McMurtry MS, Wu C. Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis. Thromb Res 2013.

Alsaleh K, Alotaibi GS, Almodaimegh HS, Aleem AA, Kouroukis CT. The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials. J Arthroplasty 2013 Mar 23.

Anderson SL, Borgelt LM. Case report: a perforated levonorgestrel-releasing intrauterine device (LNG IUD) requiring laparoscopic removal. Am Fam Physician 2013;88:364-5.

Anderson SL, Marrs JC. Probable interaction between warfarin and divalproex sodium. J Pharm Technol 2014;30:8-12.

Anderson SL, Vande Griend JP. Quetiapine for the treatment of insomnia: a review of the literature. Am J Health Syst Pharm 2014;71:394-402.

Barnett SD, Ulrich C, Baker J, Buxton ILO. The role of S-nitrosylated profiling-1 and myosin regulatory light chain 9 in human myometrial contractile dynamics. FASEB J 2013;27:879.1.

Burkin H, Rice M, Sarathy A, Thompson S, Singer CA, Buxton ILO. Integrin upregulation and localization to focal adhesion sites in pregnant human myometrium. Reprod Sci 2013;20:804-12.

Cox CD, Peeters MJ, Stanford BL, Seifert CF. Pilot of peer assessment within experiential teaching & learning. Curr Pharm Teach Learn 2013;5:311-20.

Danforth KN, Patnodet CD, Kapka TJ, Butler MG, Collins B, Compton-Phillips A, Baxter RJ, Weissberg J, McGlynn EA, Whitlock EP. Comparative effectiveness topics from a large, integrated delivery system. Perm J 2013;17:4-13.

Elperin DT, Pelter MA, Deamer RL, Burchette RJ. A large cohort study evaluating risk factors associated with uncontrolled hypertension. J Clin Hypertens 2014;16:149-54.

Heyman NS, Cowles CL, Barnett SD, Wu YY, Singer CA, Leblanc N, Buxton ILO. Regulation of TREK-1 currents in smooth muscle cells from pregnant human myometrium. Am J Physiol.

Irons BK, Trujillo A, Seifert CF, Simoni J, Doctolero S, Abo-Salem E, Meyerrose GE. Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus. J Cardiovasc Pharmacol Ther 2013. Available at http://cpt.sagepub.com/content/early/2013/06/07/1074248413489772.full.pdf+html.

Ochoa PS, Vega JA. Concepts in Sterile Preparations and Aseptic Technique [book].

Olin JL, Williams SW, Dirks-Naylor AJ. Omacetaxine mepesuccinate: a novel mRNA translation inhibitor for drug-resistant chronic myelogenous leukemia. J Hematol Oncol Pharm 2013;3:112-20.

Rackham DM, Herink MC, Stevens IG, Cardoza NM, Singh H. Evidence behind FDA alerts for drugs with adverse cardiovascular effects: implications for clinical practice. Pharmacotherapy. Published online ahead of print, December 2013.

Raebel MA, Goodrich GK, Xu S, Schroeder EB, Schmittdiel JA, Segal JB, Butler MG, Steiner JF. Initial antihyperglycemic drug therapy among 241,327 adults with newly identified diabetes from 2005 through 2010: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. Ann Pharmacother 2013;47:1280-91.

Salih SB, Yousuf M, Durihim H, Almodaimegh H, Tamim H. Prevalence and associated factors of polypharmacy among adult Saudi medical outpatients at a tertiary care center. J Fam Community Med 2013;10:162-7.

Seifert CF, Wiltrout TR. Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors. Clin Ther 2013;35:1412-7.

Tse SM, Li L, Butler MG, Fung V, Kharbanda EO, Larkin E, Vollmer WM, Miroshnik I, Rusinak D, Weiss ST, Lieu TA, Wu AC. Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med 2013;188:1076-82.

Ulrich C, Quilici DR, Schlauch KA, Buxton ILO. The human uterine smooth muscle S-nitrosoproteome fingerprint in pregnancy, labor and preterm labor. Am J Physiol Cell Physiol 2013;305:C803-816.

Vilella AL, Limsuwat C, Williams DR, Seifert CF. Cholestatic jaundice as a result of combination designer supplement ingestion. Ann Pharmacother 2013;47:e33.

Vilella AL, Seifert CF. Timing and appropriateness of initial antibiotic therapy in newly presenting septic patients. Am J Emerg Med 2014;32:7-13.

Wong S, Yokdang N, Speirs K, Buxton ILO. Purinergic mechanisms in breast cancer development: a role for nucleoside diphosphate kinase. FASEB J 2013;27:1104.9.

Woytowish MR, Maynor LM. Clinical relevance of linezolid-associated serotonin toxicity. Ann Pharmacother 2013;47:388-97.

 

New ACCP Fellows:

Michele Y. Splinter, Pharm.D., BCPS: University of Oklahoma HSC.

Zachary A. Stacy, Pharm.D., BCPS: St. Louis College of Pharmacy.

Jeffrey S. Stroup, Pharm.D., BCPS: Oklahoma State University.

Toby C. Trujillo, Pharm.D., BCPS: University of Colorado.

Nancy S. Yunker, Pharm.D., BCPS: Virginia Commonwealth University.

 

Other Notable Achievements:

Hind Almodaimegh, Pharm.D., FCCP, FISMP, BCPS: Received appreciation certificate from Saudi Ministry of Health for participation in Saudi National Atrial Fibrillation Management Guidelines.

Sarah L. Anderson, Pharm.D., BCPS: Recipient of one of six ASHP 2013 Best Practices Awards for “Implementation of a Clinical Pharmacy Specialist–Managed Telephonic Hospital Discharge Follow-up Program in a Patient-Centered Medical Home.”

Lindsay M. Arnold, Pharm.D., BCPS: Received faculty appointment to clinical assistant professor of medicine at Boston University School of Medicine.

Iain O. Buxton, Pharm.D., FAHA: Became Foundation Professor, University of Nevada School of Medicine.

Eric Kowalek, Pharm.D., BCPS: Attained certification as a BCPS.

Christie Nelson, Pharm.D.: Promoted to pharmacy clinical coordinator.

Daniel M. Rackham, Pharm.D., BCPS: Appointed to IRB chair position, Samaritan Health Services IRB, Corvallis, South Carolina.

Leslie Richard, Pharm.D.: Attained certification as a BCPS and a CGP.

Mickala M. Thompson, Pharm.D., BCPS, BCNSP: Attained BCNSP certification.

Introduction:

The Ambulatory Care PRN motto for this year is “Building Better.” Membership in the Ambulatory Care PRN has now reached 1800 members! Our committee chairs and members have been challenged with exploring new and innovative ways to serve  the Ambulatory Care PRN members. The committees were slightly restructured this year, with the Student/Resident Committee being divided into an individual Student Committee and an individual Resident Committee, with the hope of increasing and improving student and resident involvement in the PRN. The Education Committee developed a webinar for students and residents to help them understand and improve their interviewing skills for their first residency or professional position. In addition, the Ambulatory Care PRN is offering 10 ACCP Academy registrations for its members. The PRN officers and committee chairs have been meeting periodically to provide updates to the PRN regarding committee activities; these business minutes can be located on the ACCP Ambulatory Care PRN Web page.

 

Promotions:

Douglas Anderson, Cedarville University: Granted tenure.

Justin Bouw: Promoted to residency program director for the California Northstate University/Sutter Health PGY1 Residency Program.

Brad Wright, Auburn University Harrison School of Pharmacy: Promoted to associate clinical professor.

 

Awards:

Sarah Anderson: 2013 ASHP Best Practices Award.

Andrew Bzowyckyj: Received the 2013–2014 AACP New Investigator Award, $9700.

Dave Dixon: Received the Associate of the American College of Cardiology (AACC) designation from ACC; will be recognized at convocation at the 2014 ACC annual meeting.

Tracy Fame: Received the 2013–2014 AACP New Investigator Award, $10,000.

Carlisha Gentles: Received the APhA Immunization Champion Award – Individual Practitioner Category.

Elisa Greene: Received the Team Building Award: Finalist, Siloam Family Health Center Pharmacy Program Development. The Frist Foundation: Salute to Excellence, 2013.

Eric Ip: Received the 2013 JMCP Award for Excellence, Honorable Mention, for the following: Yu J, Shah BM, Ip EJ, Chan J. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California. J Manag Care Pharm 2013;19:102-14.

Christina Madison: Received Honorable Mention: 2014 Pharmacy Today One to One Patient Counseling Recognition Program (sponsored by APhA) (one of only 20 pharmacists to receive this award in the country). Southern Nevada Immunization & Health Coalition (SNIHC) Silver Syringe Award: Recipient – 2013 Immunization Education Champion of the Year.

Whitney Maxwell: Received the South Carolina College of Pharmacy Faculty Extra Mile Award.

Mary Beth O’Connell: Received the Building Michigan’s Health Care Workforce Award for Interprofessional Teamwork Initiative; Michigan Health Council.

Robert Talbert: Received the Robert K. Chalmers Distinguished Teachers Award.

Alexandra Vance: Received the Navy Civilian Pharmacist of the Year Award, November 2013.

 

Grant:

Melissa Butler, Pharm.D., BCPS, MPH: Atlanta Clinical and Translational Science Institute – Pilot Grants: Using a Holistic Approach to Understand Medication Adherence in Hypertension.

 

Publications:

Afonso N, Mendez J, O’Connell MB, Bugdalski-Stutrud CA, Smith GB, Waites C, Bowers C, Bruer S. Experiential interprofessional education using an older adult home visit. Med Sci Educ 2013;23:583-6.

Anderson SL, Borgelt LM. Case report: a perforated levonorgestrel-releasing intrauterine device (LNG IUD) requiring laparoscopic removal. Am Fam Physician 2013;88:364-5.

Anderson SL, Marrs JC. Probable interaction between warfarin and divalproex sodium. J Pharm Technol 2014;30:8-12.

Anderson SL, Vande Griend JP. Quetiapine for the treatment of insomnia: a review of the literature. Am J Health Syst Pharm 2014;71:394-402.

Beachy SH, Johnson SG, Olson S, Berger AC, rapporteurs. Refining Processes for the Co-development of Genome-Based Therapeutics and Companion Diagnostic Tests: A Workshop Summary. Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine (US). Washington, DC: National Academies Press, 2014.

Bishop MA, Streiff MB, Ensor CR, Tedford RJ, Russell SJ, Ross PA. Pharmacist-managed INR patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J. Accepted for publication.

Bussey HI, Bussey M, Bussey-Smith KL, Frei CR. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin K with genomic considerations; a pilot study. Pharmacotherapy 2013;33:1136-46.

Caudle K, Klein T, Hoffman J, Iwuchukwu O, Tyndale R, Schwab M, Relling M, Whirl-Carillo M, McDonagh E, Scott S, Johnson SG. Clinical use of biomarkers in drug metabolism and adverse drug reactions. Curr Drug Metab 2014 Jan 30.

Clancy JP, Johnson SG, Yee SW, McDonagh EM, Caudle KE, Klein TW, Cannovo M, Giacomini KM. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for ivacaftor therapy based on CFTR genotype. Clin Pharmacol Ther. In press.

Clark NP, Delate T, Riggs CS, et al. Warfarin interactions with antibiotics in the ambulatory care setting. JAMA Intern Med [Internet]. 2014 Jan 20. Available at http://archinte.jamanetwork.com/article.aspx?articleid=1813223.

Danforth KN, Patnode CD, Kapka T, Butler MG, Compton-Phillips A, Baxter RJ, Weissberg J, McGlynn E, Whitlock EP. Comparative effectiveness topics from a large, integrated delivery system. Perm J 2013;17:4-13.

Dixon DL, Bolick JP, Godishala LM, Kris-Etherton PM, Nash DT, Neri L, Warren WS. Clinician’s toolkit: a guide to medication and lifestyle adherence. Lipid Spin 2013;11(suppl 1):1-20.

Dixon DL, Kim J. The current status of amiodarone adverse event monitoring. Cardiology Today, December 2013. Available at www.healio.com/cardiology/arrhythmia-disorders/news/print/cardiology-today/%7Bd4e5ef19-34f4-408a-a506-6bcae23a9def%7D/the-current-status-of-amiodarone-adverse-event-monitoring.

Dixon DL, Sisson EM. Ten Things Every Clinician Should Know About the 2013 ACC/AHA Lipid Guidelines. iForumRx.org 2013. Available at www.iforumrx.org/node/183.

Dixon DL, Sisson EM, Butler M, Higbea A, Muoio B, Turner B. Lomitapide and mipomersen novel lipid-lowering agents for the management of familial hypercholesterolemia. J Cardiovasc Nurs 2013 Nov 13. [Epub ahead of print]

Dvorkin Camiel L, Goldman-Levine JD. Herbal products for the treatment of type 2 diabetes. Pract Diabetol 2013;32:25-30.

Edwards KL, Chastain LM. Guidelines and treatment of hyperglycemia. In: American College of Clinical Pharmacy, ed. Ambulatory Care Self-Assessment Program. Endocrinology and Rheumatology. Kansas City, MO: American College of Clinical Pharmacy, 2014:3-25.

Edwards KL, Salvo MC, Ward KE, et al. Assessment and revision of clinical pharmacy practice Internet web sites. Ann Pharmacother 2014;48:258-67.

Farland MZ, Byrd DC, McFarland MS, Thomas J, Franks AS, George CM, Gross BN, Guirguis AB, Suda KJ. Pharmacist-physician collaboration for diabetes care: the diabetes initiative program. Ann Pharmacother 2013;47:781-9.

Francart SF, Hawes EM, Deal AM, Adcock DM, Gosselin R, Jeanneret C, Friedman KD, Moll S. Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels. Thromb Haemost 2014 Jan 9. [Epub ahead of print]

Franklin B, Farland M, McFarland MS, Thomas J, Ray S, Byrd D. Pharmacoeconomic analysis of the diabetes initiative program: a pharmacist-physician collaborative care model. Ann Pharmacother 2013;47:1627-34.

Galdo J, Thurston MM, Bourg CA. Clinical considerations in insulin pharmacotherapy in ambulatory care: a two-part series. Clin Diabetes. In press. (Part One: In press, Clin Diabetes)

Goldman-Levine JD. Introduction. In: Individualizing therapy for the patient with type 2 diabetes: focus on insulin, emerging therapies, and patient management. US Pharm 2013;(suppl):4-6.

Goldman-Levine JD. Basal insulin: historic use and emerging therapies. In: Individualizing therapy for the patient with type 2 diabetes: focus on insulin, emerging therapies, and patient management. US Pharm 2013;(suppl):7-14.

Goldman-Levine JD. Canagliflozin: a new drug for type 2 diabetes. Diabetes Self Manage 2013;July/Aug:30-2.

Greene E, Fairclough J, Haines S. An exploratory study of student pharmacists’ perceived value of specific and general learning objectives. Curr Pharm Teach Learn 2014;6:135-42.

Gubbins PO, Micek S, Badowski M, Cheng J, Gallagher J, Gerrald-Moore K, Johnson SG, Karnes J, Lyons K, Strnad K. Innovation in pharmacy practice and the state of the academic-practice partnership: a commentary by the 2013 ACCP Task Force on Practice Innovation. Pharmacotherapy. In press.

Hawes EM, Maxwell W, Mangun J, Lin FC, White SF. Impact of an outpatient pharmacist intervention on medication discrepancies and health care resource utilization in posthospitalization care transitions. J Prim Care Community Health 2014;5:14-8.

Hawes EM, Maxwell WD, Ford SK, Mangun J, Lin FC. Effect of pharmacist intervention on medication discrepancies and healthcare resource utilization at post-hospitalization care transitions. J Prim Care Community Health 2014;5:14-8.

Helling DK, Johnson SG. Defining and advancing ambulatory care pharmacy practice: it is time to lengthen our stride. Am J Health Syst Pharm. In press.

Helling DK, Johnson SG. Perspectives on the future of postgraduate pharmacy training and its impact on evolving pharmacy practice. Am J Health Syst Pharm. In press.

Howard-Thompson A, Farland MZ, Byrd DC, Airee A, Thomas J, Campbell J, Cassidy R, Morgan T, Suda KJ. Pharmacist-physician collaboration for diabetes care: cardiovascular outcomes. Ann Pharmacother 2013;47:1471-7.

Ip EJ. Diabetes. In: Shapiro K, Brown SA, McNatty D, eds. RxPrep Course Book – A Comprehensive Course for the NAPLEX^® & CPJE. San Diego: RxPrep, 2014:393-428.

Irwin AN, Johnson SG, Joline BR, Delate T, Witt DM. A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertension. Thromb Res. Original Research. In press.

Jackevicius C, Ip EJ. Chronic stable angina. In: Shapiro K, Brown SA, McNatty D, eds. RxPrep Course Book – A Comprehensive Course for the NAPLEX^® & CPJE. San Diego: RxPrep, 2014:642-50.

Johnson SG, Delate T, Boka A, Shaw PB, Zager C. Characterizing the financial burden of pulmonary arterial hypertension within an integrated healthcare delivery system. J Med Econ 2013;16:1414-22.

Kelly M, Dixon D. Interim results from a cardiologist-pharmacist collaboration to improve blood pressure in an ambulatory cardiology clinic. Pharmacotherapy 2013;33:e271. Abstract 296.

McFarland MS, Wallace J, Parra J, Baker J. Evaluation of patient satisfaction with diabetes management provided by clinical pharmacists in the patient-centered medical home. Patient 2014;7:115-21.

Meyer S, Frei CR, Daniels KR, Forcade NA, Bussey M, Bussey-Smith KL, Bussey HI. Impact of a new method of warfarin management on patient satisfaction, time, and cost. Pharmacotherapy 2013;33:1147-55.

Minor DS, Meyer AM, Long RC, Butler KR. Beta-blockers and chronic obstructive pulmonary disease: inappropriate avoidance? J Clin Hypertens 2013;15:925-30.

Muir AJ, Gong L, Johnson SG, Ta M, Lee M, Williams M, Klein TE, Nelson D. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IL28B genotype with peginterferon alpha based regimens. Clin Pharmacol Ther 2013 Oct 4. [Epub ahead of print]

O’Connell MB, Jackson AN, Karaoui LR, Rodriguez de Bittner M, Chen AMH, Echeverri M, Vyas D, Poirier T, Lee S, O’Neil CK. Cultural competency in health care and its implications for pharmacy. Part 3B: emphasis on pharmacy education policy, procedures, and climate. Pharmacotherapy 2013;33:e368-e381.

O’Connell MB, Rodriguez de Bittner M, Poirier T, Karaoui LR, Echeverri M, Chen AMH, Lee S, Vyas D, O’Neil CK, Jackson AN. Cultural competency in health care and its implications for pharmacy. Part 3A: emphasis on pharmacy education curriculums and future directions. Pharmacotherapy 2013;33:e347-e367.

Page C, Hawes EM. Haemolytic anaemia after ingestion of Neem (Azadirachta indica) tea. BMJ Case Rep 2013 Oct 7 (pii: bcr2013200890).

Raebel MA, Goodrich GK, Xu S, Schroeder EB, Schmittdiel JA, Segal JB, Butler MG, Steiner JF. Initial antihyperglycemic drug therapy among 241,327 adults with newly identified diabetes from 2005 through 2010: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. Ann Pharmacother 2013;47:1280-91.

Riche D, Goldman-Levine JD. Uncovering and managing hypoglycemia: the pharmacist’s role. In: Individualizing therapy for the patient with type 2 diabetes: focus on insulin, emerging therapies, and patient management. US Pharm 2013;(suppl):21-9.

Schumacher C, Glosner S. Assessment of the pain experience and impact of care among patients with painful diabetic peripheral neuropathy. J Am Pharm Assoc 2014;54:475-9. Peer reviewed.

See S. Rediscovering community – reflections after Hurricane Sandy. Ann Fam Med 2013;11:571-3.

Shelquist R, Greene E. House calls, healthcare, and hope: one student’s perspective. Innovations 2014;5:1-2.

Sparkes S, Lyden-Fortier S, Goldman-Levine JD. When diet and exercise are just not enough: new medications for weight loss. AADE in Practice 2013;42-5.

Thurston MM, Phillips BB, Bourg CA. Safety and efficacy of allopurinol in chronic kidney disease. Ann Pharmacother 2013;47:1507-16.

Tse SM, Li L, Butler MG, Fung V, Kharbanda EO, Larkin E, Vollmer WM, Miroshnik I, Rusinak D, Weiss ST, Lieu TA, Wu AC. Statin exposure is associated with decreased asthma-related emergency department visits and oral corticosteroid use. Am J Respir Crit Care Med 2013;188:1076-82.

Venteicher M, Atherton A, Otto P, Stock C. Correlation and economic analysis assessing point-of-care anticoagulation management vs current outside laboratory agreements. Fed Pract 2014;31:23-31.

Volger EJ, McLendon AN, Fuller SH, Herring CT. Prevalence of self-reported nonmedical use of prescription stimulants in North Carolina doctor of pharmacy students. J Pharm Pract 2013 Dec 5. [Epub ahead of print]

Wallace JP, Wallace JL, McFarland MS. Comparing dosing of basal insulin analogues detemir and glargine: is it really unit-per-unit and dose-per-dose? Ann Pharmacother 2014 Jan 6. [Epub ahead of print]

 

New ACCP Fellows:

Samuel G. Johnson, Pharm.D., FCCP, BCPS (AQ Cardiology): Clinical pharmacy specialist, applied pharmacogenomics, Kaiser Permanente; clinical assistant professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.

Sarah Westberg, Pharm.D., FCCP, BCPS: Associate professor, University of Minnesota College of Pharmacy.

Alan Zillich, Pharm.D., FCCP: Research scientist, Roudebush VA Medical Center, Center of HealthCare Information and Communication; associate professor, Purdue University College of Pharmacy.

 

Other Notable Achievements:

Certifications:

Andrew Bzowyckyj: Certified Diabetes Educator.

Gabriella Douglass: American Academy of HIV Medicine (AAHIVM); AAHIVM HIV Pharmacist (AAHIVP).

Tracy Frame: Board Certified Ambulatory Care Pharmacist.

Melody Hartzler: Board Certified Ambulatory Care Pharmacist.

Christina Madison: American Academy of HIV Medicine (AAHIVM); AAHIVM HIV Pharmacist (AAHIVP).

Leslie Richard: Board Certified Pharmacotherapy Specialist.

Marissa Salvo: Board Certified Ambulatory Care Pharmacist.

Robyn Teply: Board Certified Ambulatory Care Pharmacist.

Emily Volger: Board Certified Ambulatory Care Pharmacist.

Kelly Wright: Board Certified Ambulatory Care Pharmacist and Certified Tobacco Treatment Specialist.

 

Innovations in Practice:

Bussey H, Nutescu E. ClotFree – INR self testing with online remote monitoring and management (STORM2). Presented at: Innovators Challenge at the 10th Annual Partners HealthCare’s Connected Health Symposium; October 25, 2013; Boston, MA.

 

Media Appearances:

Dixon D: MedPage Today. LDL no longer target of kidney disease lipid management. T. Neale. December 9, 2013.

Dixon D: Bloomberg News. Annual doctor visits will increase cholesterol drug use. M. Cortez. November 14, 2013.

Salvo M: Highlighted in the “A Minute With” section in the January issue of APhA’s Pharmacy Today.

 

Other:

Bourg C. Workshop: evaluating your interviewing skills. Presented at: ASHP Student Programming, Midyear Clinical Meeting; December 1, 2013; Orlando, FL.

Howard-Thompson A: Graduated from the ACCP Teaching and Learning Certificate Program.

Introduction:

The ACCP Cardiology PRN established a formalized internal committee structure immediately after the 2013 ACCP Annual Meeting in October. Named committees, chairs, charges, and policies were established and disseminated by November 30, 2013. In addition, the PRN leadership has been discussing its role in, and opportunities for, improving Cardiology PRN–initiated scholarship, which includes establishing a task force to assess how to foster additional PRN collaboration.

 

Promotions:

Vicki Groo: Promoted to clinical associate professor in the College of Pharmacy, Department of Pharmacy Practice, and in the College of Medicine, Section of Cardiology.

Farzana Musawwir: Promoted to critical care clinical pharmacist at Baltimore Washington Medical Center (a newly created position).

Barbara Wiggins: Promoted to adjunct professor at South Carolina College of Pharmacy.

 

Awards:

William Dager: Awarded the UCSF Apples for Preceptor Award; the UC Davis Medical Center Lifetime Achievement Award; and the Society of Critical Care Medicine Presidential Citation.

Dave Dixon: Received the Associate of the American College of Cardiology (AACC) designation from ACC and will be recognized at convocation at the 2014 ACC annual meeting.

Douglas Jennings: Received the Associate of the American College of Cardiology (AACC) designation from ACC and will be recognized at convocation at the 2014 ACC annual meeting.

Farzana Musawwir: Attained certification as a Board Certified Pharmacotherapy Specialist.

Tien Ng: Awarded Professor of the Year for the third consecutive year at the University of Southern California School of Pharmacy.

Toni Ripley: Received the University of Oklahoma Health Sciences Center Regents’ Award for Superior Teaching.

Eman Younis: Received a letter of appreciation/commendation from the World Health Organization (WHO) for participating in a national campaign on hand hygiene in the WHO global annual campaign on hand hygiene (SAVE Lives: Clean Your Hands)[KS1] ; received an appreciation certificate from the executive hospital director of PSCCH for participating as a speaker in the first and second Medication Safety Campaign; received an appreciation certificate from the directorate of health affairs Alhassa. This is the first certificate for efforts made in the training of pharmacy students and the second for participating in International Infection Control Week Celebration; and earned Added Qualifications in Cardiology and is the second person to receive this certification in Saudi Arabia.

 

Grants:

James Coons: Principal investigator for Pharmacist-Delivered Pharmacogenomic Care. American Society of Health-System Pharmacists (ASHP) Research and Education Foundation Pharmacy Practice Model Initiative (PPMI) Demonstration Grant. April 2013. Grant total: $24,961. Coons JC, Empey PE, Smith AJ, et al.

Shannon Finks: Principal investigator for the Course Director’s/Instructor’s Interpretation of Item Analysis for Integrated Examinations and Subsequent Impact on Student Academic Performance UTCOP Scholarship of Teaching and Learning Seed Grant Program 2013. Accepted and fully funded for $1600, August 12, 2013.

Cynthia Jackevicius: Coinvestigator for the following grant: Canadian Institutes for Health Research, coinvestigator (2014–2016): Population-Based Evaluation of Ablation Therapies in Atrial Fibrillation, $189,244.

Tien Ng: Principal investigator for an investigator-initiated grant for about $217,000 from Otsuka America Pharmaceuticals to conduct the prospective study titled the “Aquaresis Utility for Hyponatremic Acute Heart Failure (AQUA-AHF) Study.”

 

Publications:

Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-induced nephropathy: a prospective randomized study. J Interv Cardiol 2013;26:90-6.

Baker WL, Chamberlin KW. New oral anticoagulants versus warfarin treatment – no need for pharmacogenomics? Point-Counterpoint. Clin Pharmacol Ther. In press.

Baker WL, Smyth LR, Riche DM, Bourret EM, Chamberlin KW, White WB. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis. J Am Soc Hypertens. In press.

Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR. Proton pump inhibitors and the risk for hospital-acquired Clostridium difficile infection. Mayo Clin Proc 2013;88:1085-90.

Cavallari LH, DiDomenico RJ. Ischemic heart disease In: Chisholm-Burns MA, Wells BG, Schwinghammer TL, Malone PM, Kolesar JM, Rotschafer JC, DiPiro JT, eds. Pharmacotherapy Principles & Practice, 3rd ed. Chicago: McGraw-Hill, 2013:chap 7.

Cavallari LH, DiDomenico RJ, Bress A. Ischemic heart disease. In: Katz M, Matthias K, Chisholm-Burns MA, eds. Pharmacotherapy Principles & Practice Study Guide: A Case-Based Care Plan Approach, 3rd ed. Chicago: McGraw-Hill, 2013:chap 5.

Cheng JW. Updates in antiplatelet agents used in cardiovascular diseases. J Cardiovasc Pharmacol 2013;18:514-24.

Cheng JW, Barillari G. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions. J Clin Pharm Ther 2014. [Epub ahead of print]

Cheng JW, Cooke-Ariel H. Pharmacists’ role in the care of patients with heart failure: review and future evolution. J Manag Care Pharm 2014;20:1-8.

Cheng JWM. Azilsartan/chlorthalidone combination therapy in blood pressure control. Integrated Blood Pressure Control 2013;6:39-48.

Coakley C, Hough A, Dwyer D, Parra D. Clinical video telehealth in a cardiology pharmacotherapy clinic. Am J Health Syst Pharm 2013;70:1974-5.

Coons JC, Clarke M, Wanek MR, et al. Safe and effective use of prostacyclins to treat pulmonary arterial hypertension. Am J Health Syst Pharm 2013;70:1716-23.

Coons JC, Schwier N, Harris J, Seybert AL. Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction. Expert Opin Drug Metab Toxicol 2014 [Early Online].

Cornbower A, Dell’Orfano H, Matta L, Cheng J. Evaluation of potassium sparing diuretics on renal function in decompensated heart failure patients: an exploratory pilot study at a tertiary academic medical center. J Pharm Clin Sci 2013;7:1-8.

Davis LE, Storjohann TD, Spiegel JJ, Beiber KM, Barletta JF. The effect of a high-fidelity simulation technique versus lecture to improve pharmacy students’ knowledge and confidence of advanced cardiac life support training. Am J Pharm Educ 2013;77:59.

DiDonato KL, Ruehter V, Odum LE, Brownfield A, Lindsey CC. Assessing student confidence and understanding with the immunization process through implementation of an immunization protocol at a school of pharmacy. Curr Pharm Teach Learn 2013;5:417-23.

Dixon DL, Bolick JP, Godishala LM, Kris-Etherton PM, Nash DT, Neri L, Warren WS. Clinician’s toolkit: a guide to medication and lifestyle adherence. Lipid Spin 2013;11(suppl 1):1-20.

Dixon DL, Kim J. The current status of amiodarone adverse event monitoring. Cardiology Today 2013.

Dixon DL, Sisson EM. Ten Things Every Clinician Should Know About the 2013 ACC/AHA Lipid Guidelines. iForumRx.org 2013. Available at www.iforumrx.org/node/183.

Dixon DL, Sisson EM, Butler M, Higbea A, Muoio B, Turner B. Lomitapide and mipomersen novel lipid-lowering agents for the management of familial hypercholesterolemia. J Cardiovasc Nurs 2013 (doi: 10.1097/JCN.0000000000000104).

Dobesh P, Trujillo T, Finks SW. The role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism. Pharmacotherapy 2013;33:650-4.

Dorsch MP, Lose J, DiDomenico RJ. The effect of cardiology pharmacy credentialing on process of care measures and outcomes in myocardial infarction and heart failure. Pharmacotherapy 2014. In press.

Hagopian JC, Riney JN, Hollands JM, Deal EN. Assessment of bleeding events associated with short-duration therapeutic enoxaparin use in the morbidly obese. Ann Pharmacother 2013;47:1641-8.

Hough A, Vartan CM, Groppi JA, Reyes S, Beckey NP. Evaluation of clinical pharmacy interventions in a Veteran’s Affairs Medical Center primary care clinic. Am J Health Syst Pharm 2013;70:1168-72.

Jennings DL, Chopra A, Chambers R, Morgan JA. Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left-ventricular assist devices. Artif Organs 2014 (doi: 10.1111/aor.12254).

Jennings DL, Nemerovski CW, Kalus JK. Effective anticoagulation for a percutaneous ventricular assist device using a heparin-based purge solution. Ann Pharmacother 2013;47:1364-7.

Jennings DL, Williams CT, Morgan JA. Pentoxifylline for the treatment of hemolytic anemia in a patient who developed recurrent gastrointestinal bleeding while on continuous-flow left-ventricular assist device support. ASAIO J 2013;59:526-7.

Jennings DL, Makowski C, Chambers R, Lanfear DE. Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis. Int J Artif Organs 2014 (doi: 10.5301/ijao.5000285).

Lekura J, Williams CT, Tita C, Lanfear DE, Jennings DL. Assessing the potential of email for communicating drug-therapy recommendations to physicians in patients with heart failure and ventricular-assist devices. J Pharm Pract 2013 (doi: 10.1177/0897190013513618).

Makowski C, Jennings DL, Nemerovski CW, Kalus JS. The impact of a systematically deployed clinical pharmacy service on patient satisfaction. Ann Pharmacother 2013;47:805-10.

Kanwar M, Agarwal R, Barnes M, Coons J, et al. Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts. Curr Heart Fail Rep 2013;10:26-35.

Makkar KM, Sanoski CA, Goldberg LR, Spinler SA. An observational study of ezetimibe in cardiac transplant recipients receiving calcineurin inhibitors. Ann Pharmacother 2013;47:1457-62.

McCarren M, Furmaga E, Jackevicius CA, et al. Improvement in guideline beta-blocker prescribing in heart failure: a cluster-randomized pragmatic trial of a pharmacy intervention. J Card Fail 2013;19:525-32.

Milfred-Laforest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor C, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL II, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail 2013;19:354-60.

Milfred-Laforest SK, Chow SL, DiDomenico RJ, Dracup K, Ensor C, Gattis-Stough W, Heywood JT, Lindenfeld J, Page RL II, Patterson JH, Vardeny O, Massie BM. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy 2013;33:529-48.

Morneau KM, Reaves AB, Martin JB, Oliphant CS. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel. J Manag Care Pharm 2014;20:187-93.

Phelps SJ, McDonough SK, Parker RB, Finks SW.* Throwing a curveball: the impact of instructor decisions regarding poorly performing test questions. Am J Pharm Educ 2013;77:204.

*Corresponding author.

Prieto-Centurion V, Markos MA, Ramey NI, Gussin H, Nyenhuis S, Joo MJ, Prasad B, Bracken N, DiDomenico R, Godwin PO, Jaffe HA, Kalhan R, Pickard AS, Pittendrigh B, Schatz B, Sullivan JL, Thomashow BM, Williams MV, Krishnan JA. Interventions to reduce rehospitalizations following COPD exacerbations: a systematic review. Ann Am Thorac Soc 2014. In press.

Raina A, Coons JC, Kanwar M, et al. Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension. Pulm Circ 2013;3:116-20.

Riche DM, Baker WL, Koch CA. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels [letter to the editor]. JAMA. In press.

Odum LE, Aistrope D, Santee J, Cochran K, Bacon R. Impact of a debate on APPE students’ recognition of critical thinking and professional skills. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 13–17, 2013; Chicago, IL. Abstract published: Am J Pharm Educ 2013;77:27.

Oliphant CS, Jacobs A, Kabra R, Das P. Novel oral anticoagulants for the prevention and treatment of thromboembolism. Future Cardiol 2013;9:849-61.

Oliphant CS, Twilla JD. Pharmacists: an important resource to improve core measure performance. Hosp Top 2013;91:65-8.

Phan YL, Reffert J, Dinh B, Meyenburg L, Herring H. Residents’ perspectives: weighing your options in pursuing a second-year postgraduate residency. Am J Health Syst Pharm 2013. In press.

Ripley TL, Adamson PB, Hennebry TA, Van Tuyl JS, Harrison DL, Rathbun RC. Collaborative practice model between cardiologists and clinical pharmacists for management of patients with cardiovascular disease in an outpatient clinic. Ann Pharmacother 2014;48:412-9.

Ripley TL, Saseen JJ. Β-Blockers: a review of their pharmacologic and physiologic diversity. Ann Pharmacother. In press.

St. Peter WL, Odum LE, Whaley-Connell A. To RAS or not to RAS? The evidence and caution with renin-angiotensin system inhibition in patients with diabetic kidney disease. Pharmacotherapy 2013;33:496-514.

Shah M, Tsadok MA, Jackevicius CA, Essebag V, Eisenberg MJ, Rahme E, Humphries KH, Tu JV, Behlouli H, Pilote L. Warfarin use and the risk of stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation 2014. Published online before print 2014 Jan 22 (doi: 10.1161/CIRCULATIONAHA.113.004777).

Shah S, Coakley C, Hough A, Parra D. Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension. Ann Pharmacother 2013;47:1562-8.

Shah S, Parra D, Rosenstein RS. Acute myocardial infarction during regadenoson myocardial perfusion imaging. Pharmacotherapy 2013;33:e90-5.

Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR, Kovacs RJ. Development and validation of a risk score to predict QT-interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 2013;6:479-87.

Tourkmani AM, Al Khashan HI, Albabtain MA, Al Harbi TJ, Al Qahatani HB, Bakhiet AH. Medication adherence among patients in a chronic disease clinic. Saudi Med J 2012;33:1278-84.

Trinkley KE, Page RL II, Lien H, Yamanouye K, Tisdale JE. QT-interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin 2013;29:1729-36.

Wiggins BS, Rodgers JE, DiDomenico RJ, Miller AE, Page RL. Discharge counseling in heart failure and myocardial infarction – a best practices model developed by the members of the American College of Clinical Pharmacy’s Cardiology PRN based on the Hospital to Home (H2H) Initiative. Pharmacotherapy 2013;33:558-80.

 

Posters/Abstracts:

Jennings DL, Gellatly RM, Szandzik E, Leet A, Lanfear DE. Anticoagulation for the HeartWare HVAD: an international comparison of strategies and outcomes. Poster presented at: International Society of Heart and Lung Transplantation, 34th Annual Meeting and Scientific Sessions; April 2014; San Diego, CA. Abstract published: J Heart Lung Transplant 2014.

Jennings DL, Jacob M, Chopra A, Nemerovski CW, Morgan JA, Lanfear DE. Safety of anticoagulation reversal in patients supported with continuous-flow left-ventricular assist devices. Poster presented at: International Society of Heart and Lung Transplantation, 34th Annual Meeting and Scientific Sessions; April 2014; San Diego, CA. Abstract published: J Heart Lung Transplant 2014.

Jennings DL, Wagner JL, Nemerovski CW, Kalus JS, Morgan JA, Lanfear DE. Epidemiology and outcomes associated with anemia during long-term continuous-flow left ventricular assist device support. Poster presented at: International Society of Heart and Lung Transplantation, 34th Annual Meeting and Scientific Sessions; April 2014; San Diego, CA. Abstract published: J Heart Lung Transplant 2014.

Kelly M, Dixon D. Interim results from a cardiologist-pharmacist collaboration to improve blood pressure in an ambulatory cardiology clinic. Pharmacotherapy 2013;33:e271. Abstract 296.

Scott A, Sisson E, Pakyz A, Dixon D. Evaluation of cardiometabolic risk in an underserved population. American Society of Health-System Pharmacists Midyear Meeting; 2013; Orlando, FL.

 

New ACCP Fellows:

Karen McConnell: Elected as a Fellow of ACCP.

Kelly Rogers: Elected as a Fellow of ACCP.

Toby Trujillo: Elected as a Fellow of ACCP.

 

Other Notable Achievements:

Douglas Anderson: Granted tenure at Cedarville University School of Pharmacy, Department of Pharmacy Practice.

Dave Dixon: Interviewed by MedPage Today. LDL no longer target of kidney disease lipid management. T. Neale. December 9, 2013.

Dave Dixon: Interviewed by Bloomberg News. Annual doctor visits will increase cholesterol drug use. M. Cortez. November 14, 2013.

Cynthia Jackevicius: Elected as a fellow of the American Heart Association.

Kathleen Makkar: Appointed to the American College of Cardiology: Surviving Myocardial Infarction Implementation Work Group.

Toni Ripley: Elected as the cardiac care associate state liaison for the Oklahoma chapter of the American College of Cardiology (term 2014–2017).

Robert Talbert: Appointed to the Therapeutic Information Formulary Support Expert Committee for USP, which is the group that produces the formulary model guidelines for CMS.

Toby Trujillo: Elected as a fellow of the American Heart Association.

Barbara Wiggins: Invited to be section editor for “Statin Drugs” in Current Atherosclerotic Reports.

Barbara Wiggins: Appointed to the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Barbara Wiggins and Joseph Saseen: Coedited the second edition of Pharmacist’s Guide to Lipid Management, to be released in spring 2014.

 

Presentations:

Dixon D. Update on lipid management – where are we now? Presented at: Virginia Chapter of the American College of Cardiology, Annual Meeting; October 4, 2013; Richmond, VA.

Dixon D. Management of hypertension across the lifespan. Sponsored by: Foundation for Health Improvement & Technology. Available at www.LecturePad.org. Continuing medical education (CME) certified by the American Academy of Family Physicians; 2013–2014.

Finks S. Presented online for: ACCP’s Last Chance Pharmacotherapy Review Webinar; 2013 (aired September 4, 2013).

Finks S. Updates to the updates: cardiology I. Presented to: Webinar attendees at this ACCP-sponsored program; February 26 and 27, 2014.

Finks S. Heart failure drugs in pregnancy: what is safe? Presented at: Clinical Fundamentals III: The Pregnant Patient with Heart Failure at the 17th Annual Heart Failure Society of America (ACPE 0008-9999-13-068-L01-P, 1.5 contact hours); September 25, 2013; Orlando, FL.

McConnell K. Evidence-based screening and prevention strategies: cardiovascular disease. Presented at: American College of Clinical Pharmacy Annual Meeting; October 12, 2013; Albuquerque, NM.

McConnell K. Continuing professional development: sustainability of improvements to pharmacy practice and learning behaviors. Presented at: Accreditation Council of Pharmacy Education Bi-annual Meeting; Minneapolis, MN.

 

Publications:

• Hester EK, McBane SE, Bottorf MB, Carnes TA, Dell K, Gonyeau MJ, Greco AJ, McConnell KJ, Skaar DJ, Splinter MY, Trujillo TC. ACCP position statement: Educational outcomes necessary to enter pharmacy residency training.
• Jann MW, Kennedy WK, Lopez G. Benzodiazepines: an overlooked class of prescription drugs in unintentional overdoses. J Pharm Pract 2014;27:5-16.
• Kennedy WK, Jann MW, Kutcher E. Clinically significant drug interactions with atypical antipsychotics. CNS Drugs 2013;27:1021-48.

 

New ACCP Fellow:

• Michele Y. Splinter, Pharm.D., M.S., FCCP, BCPS; University of Oklahoma, Oklahoma City, OK.

The Clinical Administration PRN, which continues to grow, is now at an all-time high of 430 members. Since the Annual Meeting, the PRN has been actively pursuing a list of endeavors for 2014. Members are actively engaged in committees, including the Nominations Committee, the Travel Awards Committee, and the Annual Meeting Focus Session Planning Committee.

 

What’s New?

This year, the Clinical Administration PRN will offer two new travel scholarships of $500 each. The Clinical Administration PRN Travel Award is intended to provide partial financial support for students, residents, or fellows interested in administrative career paths to attend the 2014 ACCP Annual Meeting.

 

What’s All the Buzz About?

The Annual Meeting Focus Session Planning Committee has been developing a focus session that will meet the needs voiced by our members. At the Annual Meeting, the PRN will sponsor a focus session in which experts around the country will share how they have successfully used the services of pharmacy students in innovative ways to improve medication-related key performance indicators.

 

Challenge to Fellow PRNs

Clinical Administration PRN members have shown their support of the ACCP-PAC Committee by challenging each other to contribute to the ACCP-PAC. The goal is to have contributions from 50 members before the Annual Meeting. Contributions, even those as small as the cost of a cup of coffee per member, will help show that a high percentage of ACCP members are dedicated to the success of the Medicare Initiative. The Clinical Administration PRN would like to challenge other PRNs to do the same. The best show of support at this time from the ACCP membership is the percentage of members contributing to the PAC.

 

Notable Achievements

Charlene Hope, Pharm.D., BCPS, achieved double certification as a Certified Professional in Patient Safety and a Certified Professional in Healthcare Quality. Dr. Hope is currently pursuing her master’s degree in healthcare quality and patient safety at Northwestern University.

Harminder Sikand, Pharm.D., FCSHP, FASHP, clinical direction and residency director at Scripps Mercy Hospital, was recently installed as the chapter president of the San Diego Society of Health-System Pharmacists.

Angela Smith, Pharm.D., BCPS, received a WakeMed Foundation Helton Scholarship for 2014 and was named a Helton Scholar. The Helton Scholarship Endowment Fund was established by a grant from the Helton Family Foundation in appreciation of the contributions of nurses and allied health professionals to the care and well-being of patients at WakeMed. Dr. Smith, clinical pharmacy manager at WakeMed Health & Hospitals in Cary, North Carolina, was the first pharmacist to ever receive this distinguished award. Dr. Smith was also accepted into the doctorate in health administration program at the Medical University of South Carolina. She will begin her studies in August after completing a master’s degree in healthcare administration.

Introduction:

The various Critical Care PRN committees include the following: Recognition; Program; Student, Resident, and Fellow; Awards; Research; and Communications. These committees are already achieving their respective charges. The Communications Committee has published a critical care newsletter informing our PRN membership of current activities and opportunities to become involved. The Student, Resident, and Fellow Committee has developed a “Welcome Packet” for new trainees, outlining their roles and responsibilities. In addition, many of our PRN members have received various awards, promotions, and other notable achievements.

 

Award:

Joseph Dasta, M.Sc., FCCP, FCCM: Received the Russell R. Miller Award at the ACCP Annual Meeting.

 

New ACCP Fellows:

Michael L. Bentley, Pharm.D., FCCP; Carilion Clinic.

Mariann D. Churchwell, Pharm.D., FCCP, BCPS; University of Toledo College of Pharmacy.

Eric W. Mueller, Pharm.D., FCCP, FCCM; University of Cincinnati Medical Center.

Toby C. Trujillo, Pharm.D., FCCP, BCPS; University of Colorado School of Pharmacy.

 

Other Notable Achievements:

The ACCP Critical Care PRN members who presented at the Society of Critical Care Medicine 43rd Critical Care Congress, January 9–13, 2014, in San Francisco, CA, are listed below.

Jeffrey Barletta, Pharm.D., FCCM: Stop Stressing over Stress Ulcers.

Cassie A. Barton, Pharm.D.: Pharmacology Year in Review: Toxicology.

Gretchen M. Brophy, Pharm.D., FCCM, BCPS: Neuroscience Year in Review: A Year Review of Guidelines.

Mitchell S. Buckley, Pharm.D., FCCM, BCPS:

Stress Ulcer Prophylaxis: Not for Everyone; Consequences of Overuse.

Emerging Treatment Strategies and Pharmacotherapies for Managing Hyponatremia.

John W. Devlin, Pharm.D., FCCM, BCPS: Impact of Medication, Delirium and Mechanical Ventilation on Sleep in the ICU.

Amy L. Dzierba, Pharm.D., FCCM, BCPS: Pulmonary Hypertension: Medications and Novel Therapies.

Philip E. Empey, Pharm.D., Ph.D., BCPS: Pharmacogenomics of Critical Care.

Elizabeth A. Farrington, Pharm.D., FCCM, BCPS:

Update in the Management of Pediatric Acute Kidney Injury.

Drug Dosing in Pediatric Acute Kidney Injury: Small Doses, Big Challenges.

Douglas N. Fish, Pharm.D., FCCM, BCPS: Antimicrobial Stewardship: Does Controlling Antibiotics Improve Infection Control?

Judith Jacobi, Pharm.D., FCCM, BCPS: Steroids in Sepsis.

Sandra L. Kane-Gill, Pharm.D., M.S., FCCM:

Don’t Be Alarmed: Preventing the Distraction.Managing Alert Overload: Clinical Decision Support.

Tyree H. Kiser, Pharm.D., FCCM, BCPS: Dialysis in the ICU: Dosing Failure: Dialysis and Supporting Medications.

John J. Lewin III, Pharm.D., MBA, BCPS: Patient Outcomes from Drug Shortages.

Stephanie Mallow Corbett, Pharm.D., FCCM: Strategies to Deal with Shortages at the Local Level.

Wesley D. McMillian, Pharm.D., BCPS: Strategies for Implementation of Evidence-Based Protocols.

Scott Micek, Pharm.D., BCPS:

Therapeutic Drug Monitoring: A Modern Day Approach: Beta-Lactams: It’s Not Just Minimum Inhibitory Concentration.

Accountable Antibiotic Decision Making: Approaches to Current and Future Treatment Options.

Obstructive Lung Disease in the ICU: Pharmacologic Management of Obstructive Lung Disease.

James Mowry, Pharm.D., DABAT, FAACT: Extracorporeal Treatments in Poisoning Workgroup: The EX-TRIP Initiative: Rationale, Objectives and Methods.

Keith M. Olsen, Pharm.D., FCCM

Targeted Therapies for Invasive Fungal Infections: Are You Missing the Mark?

Current Strategies for Prophylaxis, Empirical Treatment, Preemptive and Targeted Therapy: What Are the Available and Emerging Therapies?

Lance J. Oyen, Pharm.D., FCCM, BCPS: Pharmacology Year in Review.

Christopher Paciullo, Pharm.D., BCPS: Anticoagulant Considerations with VADs and ERADs.

Heather A. Personett, Pharm.D., BCPS: Pharmacology Year in Review: Care of the Critically Ill Transplant Patient.

Russel J. Roberts, Pharm.D.: Drug Shortages: Lessons Learned; Pharmacology Year in Review: Substance Withdrawal.

Promotions:

• Brown JN: Promoted to adjunct professor of pharmacy practice with Campbell University College of Pharmacy and Health Sciences.
• Ficzere C: Promoted to associate professor and awarded tenure at Belmont University College of Pharmacy.
• Lewis A: Lead pharmacist, Medication Use Advancement (DI, Medication Safety, and Policy/Compliance Group).

 

Awards:

• Younis EE: Letter of appreciation/commendation from the World Health Organization (WHO) for participating in the WHO global annual campaign on hand hygiene.
• Younis EE: Appreciation certificate from the Executive Hospital Director of PSCCH for participating as a speaker in the first and second Medication Safety Campaign.
• Younis EE: Appreciation certificates from the director of health affairs for efforts made in the training of pharmacy students and for participating in the International Infection Control Week Celebration.

 

Grant:

• Gabay M: $99,270 grant from Takeda to fund a new PGY2 UIC/Takeda Drug Information Residency.

 

Publications:

• Beckett RD, Bickett S, Cole SW, Hutcherson T, McDaniel JA, Rogers HK, Seeger CM. AACP Core List of Journals for Libraries That Serve Schools and Colleges of Pharmacy [Internet], 5th ed. Alexandria, VA: Library and Information Science Section of the American Association of Colleges of Pharmacy, 2013 [cited 2013 Dec 4]. Available at www.aacp.org/governance/SECTIONS/libraryinformationscience/Documents/AACPCoreJournalsList2013.pdf.
• Brown JN, Kemp DW, Parker MH, Wilkinson S. Methods to promote preceptor scholarship through resident collaboration. Hosp Pharm 2013;48:646-9.
• Brown JN, Tiemann KA, Ostroff JL. Description of a medical writing rotation for a postgraduate pharmacy residency rotation. J Pharm Pract 2014. [Epub ahead of print]
• Conrad JL. mHealth: helping doctors treat the uninsured: a case study. In: Krohn R, Metcalf D, eds. mHealth Innovation: Best Practices from the Mobile Frontier. Chicago: Healthcare Information and Management Systems Society (HIMSS), 2014.
• Corbo JM, Brown JN, Bryan WE, Townsend ML. Impact of phosphodiesterase-5 inhibitor treatment on the rates of sexually transmitted diseases in a Veterans Affairs Medical Center patient population. J Pharm Pract 2014;27:40-5.
• Edwards KL, Salvo MC, Ward KE, et al. Assessment and revision of clinical pharmacy practice Internet websites. Ann Pharmacother 2014;48:258-67.
• Fox ER, Sweet BV, Jensen V. Drug shortages: a complex health care crisis. Mayo Clin Proc 2014;89:361-73.
• Gabay M. Federal controlled substances act: ordering and recordkeeping. Hosp Pharm 2013;48:919-21.
• Gabay M. Federal controlled substances act: controlled substances prescriptions. Hosp Pharm 2013;48:644-5.
• Gabay M. The federal controlled substances act: schedules and pharmacy registration. Hosp Pharm 2013;48:473-4.
• Gabay M. Expanding the definition of nonprescription drugs: potential impact on pharmacists. Hosp Pharm 2013;48:198-9.
• Gabay M, Boucher B. An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. Pharmacotherapy 2013;33:935-55.
• Marino AB, Cole SW. Alogliptin: safety, efficacy, and clinical implications. J Pharm Pract 2014 Feb 13. [Epub ahead of print]
• Marino AB, Cole SW, Nuzum DS. Alternative dosing strategies for liraglutide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2014;71:223-6.
• May JR, Smith PH. Drug allergies and pseudoallergies. In: Pharmacotherapy Principles and Practice, 3rd ed. New York: McGraw-Hill, 2013:965-75.
• Moss JM, Kemp DW, Brown JN. Combination inhaled corticosteroid and bronchodilator induced delirium in an elderly patient with lung disease. J Pharm Pract 2014;27:79-83.
• Nestor J, Huggins T, Kummerfeldt C, Wisniewski CS, Davis J, Doelken P, Sahn S. Dasatinib-induced chylous pleural effusions. Clin Pulm Med 2014;21:42-5.
• Olin JL, Cole SW, Dirks-Naylor AJ. Omacetaxine mepesuccinate: a novel mRNA translation inhibitor for drug-resistant chronic myelogenous leukemia. J Hematol Oncol Pharm 2013;3:112-20.
• Patil A, Patil N, Lewis A, Swamy G, Murtha A. Healthcare providers’ use of a drug information service (DIS) for pregnancy-related inquiries. J Am Pharm Assoc 2003. In press.
• Perkins SL, Cole SW. Ziv-aflibercept (Zaltrap) for the treatment of metastatic colorectal cancer. Ann Pharmacother 2013 Oct 15. [Epub ahead of print]
• Phillips H, Fuller PD, May JR, Johnson S. Conflict resolution strategies between preceptor and resident – a case-based scenario. Am J Health Syst Pharm 2014;71:184-6.
• Phillips J, Bachenheimer B. An analysis of medication errors associated with technology. KeePosted 2013;39(10). This publication is only available electronically.
• UIC Drug Information Group. Light-sensitive injectable prescription drugs. Hosp Pharm 2014;49:136-63.
• Ward KE, O’Brien B. Pregnancy and lactation: therapeutic considerations. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York: McGraw-Hill, 2014.
• Wisniewski CS, Robert S, Ball S. Collaboration between a drug information center and an academic detailing program. Am J Health Syst Pharm 2014;71:128-34.

 

Other Notable Achievements:

• Gabay M: Presented multiple lectures at: Meiji University in Tokyo, Japan, in January 2014, including presenting on “The Role of the Drug Information Pharmacist at an Academic Medical Center.”
• Hurren J, Palmer M, Elias A, Dehoorne-Smith M. Erythropoietin-stimulating agent use during transitions in care. American College of Clinical Pharmacy (ACCP) Annual Meeting; October 2013; Albuquerque, NM.
• Hussein Y, Schlaan M, May JR, May DW. Drug information status in Egypt. Poster presented at: Dubai International Pharmaceuticals and Technologies Conference; March 2014; Dubai, United Arab Emirates.
• Lewis A: Contributing author to Pharmacy Times Health-System edition and submitted six formulary drug reviews each year.
• May JR: Reappointed, Educational Steering Committee; America Society of Health-System Pharmacists, Section of Clinical Specialists and Scientists, 2013–2014.
• May JR: Member, Research and Education Committee, University Health System Consortium, 2013–2014.
• May JR. New drug update 2013: a formulary review. Presented at: University of Georgia College of Pharmacy Mental Health Symposium; February 5, 2013.
• May JR. New drug update 2013: a formulary approach. Presented at: Georgia Society of Health-System Pharmacists Fall Meeting; October 13, 2013; Young Harris, GA.
• May JR (with DeRemer D, Phillips B, Phillips M). Have you published that paper yet? Successfully precepting student and resident research projects. Presented at: ASHP National Pharmacy Preceptors Conference; August 23, 2013; Washington, DC.
• May JR, Smith KM, Phillips HJ, Fuller, PD, King M, Gross AK, Cavalieri CC, Kuhn SJ, Beardsley JR, Kumarachandran G. Teaching certificates offered by residency programs at academic medical centers. Presented at: American Association of Colleges of Pharmacy Meeting; July 15, 2013; Chicago, IL.
• McGonigal K, Thames L, Hurren J. Admission medication reconciliation accuracy at an academic medical center. Poster presented at: ASHP Midyear Clinical Meeting; December 2013; Las Vegas, NV. Poster 8-045.
• Patch M, May JR. Prolonged unneeded use of liposomal amphotericin B. Poster presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 9, 2013; Orlando, FL.
• Pegram AH, Cole SW. Evaluation of a pharmacist’s impact in a university-based wellness clinic: a pilot study. Pharmacotherapy 2013;33:e245. Abstract 209.
• Willis LM, Stiles C, Im L, May JR. Antibiotic overuse in the transition of care from inpatient to outpatient. Poster presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 9, 2013; Orlando, FL.
• Younis EE. Role of clinical pharmacist in improving pneumonia vaccination rate in cardiac patients. Poster presented at: Dubai International Pharmaceuticals & Technologies Conference & Exhibition.
• Younis EE: Earned Added Qualifications in Cardiology Pharmacotherapy (BCPS) from the Board of Pharmacy Specialties (BPS).
• Zechmeister C, Hurren J, McNorton K. Continuation of statin therapy and vasopressor use in septic shock patients. Presented at: Society of Critical Care Medicine (SCCM) 43rd Critical Care Congress; January 2014; San Francisco, CA. Abstract 2421.

The Education and Training (EDTR) PRN has grown to more than 496 members. Its mission is to promote dialogue and interaction in order to develop programs that enhance the knowledge and skills needed to provide education and training within clinical pharmacy. The PRN is pleased to share the many accomplishments of its members as we look forward to another productive year.

The EDTR PRN was once again the host of mock interviews for students and residents attending the 2013 Annual Meeting in Albuquerque. Fifty-two interviewees took advantage of this opportunity to learn key interviewing skills from clinical faculty and practitioners in preparation for residency or initial career position interviews. Thirty-seven interviewers graciously volunteered their time to make this event a success. Most participants were able to go through two rounds of mock interviews to receive valuable feedback from multiple interviewers. We look forward to offering this activity at the 2014 meeting and ask that you encourage students and residents attending the meeting to take advantage of this opportunity.

The PRN also held its first silent auction during its annual business meeting. More than $600 was raised, which will be used to increase the EDTR PRN Student/Resident Travel Scholarships from two to three awards for the upcoming year. We hope to make this an annual event so that we can continue to increase our support of student and resident members. The PRN would like to thank the following members for their generous donations: P. Brandon Bookstaver, Sherry Brown, Sandra Caballero, Lauren Czosnowski, Gloria Meredith, Sarah Nisly, Beth H. Resman-Targoff, Jim Scott, Karen Shapiro, and Rebecca Sleeper.

The Student and Postgraduate Trainee Support Committee has worked with the PRN membership to increase the EDTR PRN travel awards to three (two students and one postgraduate trainee) for the 2014 Annual Meeting. Watch the EDTR PRN e-mail list, as well as the Student and Resident sections of ACCP’s Web site, for additional information.

The Scholarly Activities Committee is pleased to be offering enduring programs on a YouTube channel created specifically for the EDTR PRN. The first program, “Primer on Psychometric Issues with Educational Testing” by Michael J. Peters, Pharm.D., MEd, BCPS, will be available for viewing at your convenience by a link available through the PRN homepage. Information regarding how to access the program will be circulated through the PRN’s e-mail list, but you may also contact Tina Denetclaw (chair of the Scholarly Activities Committee), Danny Riche (vice chair of the Scholarly Activities Committee), or any of the PRN officers for additional information. Continue to watch the EDTR PRN e-mail list for information concerning additional programs to be offered in the future.

The ACCP Updates in Therapeutics^® meeting will host PRN networking mornings, as in past years. If you are attending the spring Updates in Therapeutics^® or Academy sessions, please stop by on either Saturday or Sunday from 7:00 a.m. to 8:30 a.m. to visit with PRN officers. Please also encourage nonmembers to join us for this networking session to learn more about the PRN. Consult the meeting programming calendar for more information regarding location.

The EDTR is proud of its growing membership, and the PRN would like to continue expanding. We encourage ACCP members who are interested in promoting our mission to join the EDTR PRN and take an active role on a committee.

 

Promotions:

Douglas C. Anderson, Pharm.D., D.Ph.: Granted tenure with the Department of Pharmacy Practice at Cedarville University School of Pharmacy.

Diane Rhee, Pharm.D.: Promoted to associate professor of pharmacy practice at Roseman University of Health Sciences.

 

Publications:

P. Brandon Bookstaver, Pharm.D., BCPS (AQ-ID), AAHIVP

Bookstaver PB, Bland CM, Qureshi ZP, Faulkner-Fennell CM, Sheldon MA, Caulder CR, Hartis C. Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States. Pharmacotherapy 2013;33:1322-30.

Bookstaver PB, Rokas KE, Norris LB, Edwards JM, Sherertz RJ. Stability and compatibility of antimicrobial lock solutions. Am J Health Syst Pharm 2013;70:2185-98.

Edwards KL, Salvo MC, Ward KE, Attridge RT, Kiser K, Pinner NA, Gallegos PJ, Kesteloot LL, Hylton A, Bookstaver PB. Assessment and revision of clinical pharmacy practice Internet web sites. Ann Pharmacother 2013 Nov 12. [Epub ahead of print]

Tina Denetclaw, Pharm.D., BCPS

Denetclaw TH, Cefalu P, Manila R, Panagotacos J. Needs analysis for educating community pharmacists to interface with prehospital stroke chain of survival. J Stroke Cerebrovasc Dis 2014;23:209-12.

Denetclaw TH, Dowling TC, Steinke D. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients. Ann Pharmacother 2013;47:1611-7.

Justine S. Gortney, Pharm.D., BCPS

Gortney JS, Lundquist LL. Experience and evaluation of oral examinations in a therapeutics course for second year pharmacy students. Curr Pharm Teach Learn 2013;5:321-30.

Gortney JS, Seed S, Borja-Hart N, Young V, Woodard LJ, Nobles-Knight D, Scott DM, Nash J. Assessing the prevalence and characteristics of dual Pharm.D./MPH programs offered at colleges/schools of pharmacy in the United States. Am J Pharm Educ 2013;77:Article 116.

Lamis R. Karaoui, Pharm.D., BCPS

American College of Clinical Pharmacy; O’Connell MB, Jackson AN, Karaoui LR, Rodriguez de Bittner M, Chen AM, Echeverri M, et al. Cultural competency in health care and its implications for pharmacy. Part 3B: emphasis on pharmacy education policy, procedures, and climate. Pharmacotherapy 2013;33:e368-81.

American College of Clinical Pharmacy; O’Connell MB, Jackson AN, Karaoui LR, Rodriguez de Bittner M, Chen AM, Echeverri M, et al. Cultural competency in health care and its implications for pharmacy. Part 3A: emphasis on pharmacy education, curriculums, and future directions. Pharmacotherapy 2013;33:347-67.

Chahine EB, Karaoui LR, Mansour H. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann Pharmacother 2014;48:107-15.

Samantha Karr, Pharm.D., BCPS

Karr S, Buckley (Bohling) K, Gurney M. Journal club facilitation. In: Westberg, SM, ed. ACCP Ambulatory Care New Practitioner Survival Guide/Resource Manual, 3rd ed. Lenexa, KS: American College of Clinical Pharmacy, 2013:331-7.

Sarah A. Nisly, Pharm.D., BCPS

Harris S, Nisly SA, Aykroyd L, Carroll J, Ulmer B, Waddell M, et al. Use of a subcutaneous insulin computerized GlucoStabilizer™ program on glycemic control in the intensive care setting: a retrospective data analysis. Adv Diabetes Metab 2013;1:29-35.

Isaacs A, Doolin M, Morse C, Nisly SA. Medication utilization evaluation of dabigatran and rivaroxaban within a large multicenter health system. JHPR 2013;2:1-7.

Nisly SA, Shiltz ED, VanArsdale V, Laughlin J. Implementation of an order set to adhere to national patient safety goals for warfarin therapy. Hosp Pharm 2013;48:1-6.

Michael J. Peeters, Pharm.D., MEd, BCPS

Hoover MJ, Jacobs DM, Jung R, Peeters MJ. Validity and reliability with educational testing in the pharmacy and medical literature. Am J Pharm Educ 2013;77:Article 213.

Peeters MJ, Beltyukova SA, Martin BA. Improving rigor in scholarship of teaching & learning: a primer on educational testing and validity of conclusions. Am J Pharm Educ 2013;77:Article 186.

Peeters MJ, Schmude KA, Steinmiller CL. Reliability consequences with PharmD admissions essays rubric developments. Curr Pharm Teach Learn 2014;6:(online).

Peeters MJ, Serres ML, Gundrum TE. Improving reliability of a residency interview process. Am J Pharm Educ 2013;77:Article 168.

Beth H. Resman-Targoff, Pharm.D., FCCP

Resman-Targoff BH. Systemic lupus erythematosus. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York: McGraw-Hill, 2014.

 

Other Notable Achievements:

Bruce Edgren, Pharm.D.: Completed the Robert Wood Johnson Health Policy Fellowship in Washington, D.C.

Samantha Karr, Pharm.D., BCPS: Through vote of the PRN, will serve as official past chair for the EDTR PRN. In addition, Dr. Karr was recently Board Certified in Advanced Diabetes Management (BC-ADM).

Christina M. Madison, Pharm.D., BCACP, AAHIVP: Received credentialing from the American Academy of HIV Medicine (AAHIVM) as an AAHIVM HIV Pharmacist (AAHIVP). She also received Honorable Mention: Pharmacy Today One to One Patient Counseling Recognition Program, sponsored by APhA. She was one of only 20 pharmacists to receive this award in the country. Dr. Madison also received a 2013 Immunization Education Champion of the Year Award from the Southern Nevada Immunization & Health Coalition (SNIHC) – Silver Syringe Award.

Donald Miller, Pharm.D.: Appointed to the FDA Arthritis Advisory Committee for a term through September 2016.

Our PRN priorities parallel those of ACCP. Through the work of our committees, we develop, advance, and position clinical pharmacists to better serve their patients. As our PRN membership increases each year (see below), the number of committees continues to grow as well.

Our current committees, their respective chairs, and their updates are listed below. We extend a sincere “thank you” to all of our PRN leaders.

Committee	Chairperson	Contact e-mail
Awards and Recognition	Megan Musselman	[email protected]
CODE*	Samantha Bastow	[email protected]
Media	Craig Cocchio	[email protected]
Programming	Kyle Weant	[email protected]
Travel Award	Nicole Acquisto	[email protected]
Task Force	Chairperson	Contact e-mail
Justification	Kyle Weant	[email protected]
Student Involvement	Elaine Fosmire	[email protected]
	Lindsay Schaack	[email protected]

*Collaborative Organization for Development of Emergency Medicine Pharmacists.

 

Award/Recognition Committee

The Award/Recognition Committee supported nominations for the 2014 ACCP New Awards. The following individuals were nominated, and applications were put forth:

New Clinical Practitioner: Nicole Acquisto and Suprat Saely.

New Educator: Stephen Rolfe.

New Investigator: Darrel Hughes.

The EMED PRN would like to congratulate our nominees!

 

CODE Committee

The CODE Program encourages idea sharing and fosters professional growth by forming meaningful partnerships among emergency medicine pharmacists. The next matching process will occur in April 2014. The CODE Committee is developing a survey that will help identify aspects of the program that we can improve on, and we are excited about the positive feedback we have received so far.

 

Programming Committee

After the ACCP Annual Meeting last fall, the Programming Committee quickly began developing the focus session for our meeting next fall in Austin. Our plan is to focus on a comprehensive approach to the management of toxicologic emergencies as they pertain to wilderness medicine and illicit drug use, both in the prehospital field and in the emergency department.

 

Travel Award Committee

The Travel Award Committee will award a Student and Resident Research Travel Award this year to help support the costs of travel and attendance at the 2014 ACCP Annual Meeting. More information can be found at www.accp.com within the PRN documents of the EMED PRN section (www.accp.com/docs/prns/emed/Travel_Award_-_EMED_PRN.pdf). Recipients will present their research at the Emergency Medicine PRN Business Meeting and Networking Forum at the 2014 ACCP Annual Meeting in Austin, Texas.

 

Justification Task Force

The Justification Task Force continues its mission to provide a framework for the development of an optimal business and practice model for the emergency department. After developing an outline and structure for this framework in its inaugural year, task force members have been working diligently to elaborate on these building blocks this year. Using an extensive database of primary literature to support recommendations, task force members anticipate that an initial draft of this framework will be completed by the end of the year.

 

Student Task Force

The Student Task Force is finalizing a survey that will be sent to all student members of the ACCP EMED PRN to gauge student interest in a student committee. The task force is also creating a framework for an official PRN committee.

The Endocrine and Metabolism PRN is composed of members from a variety of practice settings. The PRN was formed to achieve the following goals and objectives. (1) Provide an opportunity for pharmacists with an interest in endocrine and metabolic disorders to promote practice, research, and education in these areas. (2) Provide a mechanism for members with similar interests to meet during ACCP meetings to network, problem solve, and discuss professional issues and opportunities. (3) Promote practice involvement; educational needs of health care professionals, students, and patients; and research activities in the areas of endocrinology and metabolism that may be favorably affected by this ACCP PRN effort.

During the past 6 months, some notable member accomplishments are as follows:

Promotion:

• Samantha Karr:
  • Promoted from assistant to associate professor, Midwestern University, College of Pharmacy, Glendale, AZ.

Grant:

• Andrew Bzowyckyj: AACP New Investigator Award titled “NPH Insulin for Prednisone-Induced Hyperglycemia.”

Publications:

• Jennifer N. Clements
  • Andres J, Clements J. A practical guide to concentrated insulin for pharmacists. J Pharm Pract. Published online, January 9, 2014.
  • Clements J. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program. Endocrinology and Rheumatology. Lenexa, KS: American College of Clinical Pharmacy, 2014:210-33.

 

• Krystal Edwards and Lisa Chastain
  • Edwards KL, Chastain LM. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program. Endocrinology and Rheumatology. Lenexa, KS: American College of Clinical Pharmacy, 2014:3-25.

 

• Katy Hurren
  • Hurren KM, Duhnam MW. In: Dong BJ, Elliott DP, eds. Ambulatory Care Self-Assessment Program. Endocrinology and Rheumatology. Lenexa, KS: American College of Clinical Pharmacy, 2014:72-86.

 

• June Felice Johnson
  • Bhargava A, Gleason S, Vaughan AG, Johnson JF, Yarlagadda KV. The effect of pioglitazone and extended-release niacin on HDL-cholesterol in diabetes patients in a real-world setting. Int J Clin Pract November 2013;67:1151-8.

 

• Samantha Karr
  • Karr S, Buckley (Bohling) K, Gurney M. Journal club facilitation. In: Westburg SM, ed. ACCP Ambulatory Care New Practitioner Survival Guide/Resource Manual, 3rd ed. Lenexa, KS: American College of Clinical Pharmacy, 2013:331-7.

 

• Christie Schumacher
  • Schumacher C, Glosner S. Assessment of the pain experience and impact of care among patients with painful diabetic peripheral neuropathy. J Am Pharm Assoc 2014;54:475-9.

 

Presentations:

• Katy Hurren: Pharmacotherapy for obesity. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2013; Orlando, FL.
• Nicole R. Pinelli: Capturing collective implementation experiences of clinicians using the layered learning practice model. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2013; Orlando, FL.

 

New ACCP Fellow:

• Sarah M. Westberg, Pharm.D., FCCP, BCPS: University of Minnesota College of Pharmacy, Minneapolis, MN.

 

Other Notable Achievements:

• Andrew Bzowyckyj: Received CDE recognition.
• June Felice Johnson: Appointed board member of the American Diabetes Association-Central Iowa Chapter.
• Samantha Karr: Received BC-ADM recognition.
• Drew L. Klinkebiel: Received CDE recognition.
• Devada Singh-Franco: Received CDE recognition.
• The Endocrine and Metabolism PRN would like to congratulate the following members who passed the ambulatory care pharmacy specialty certification offered by the Board of Pharmacy Specialties in October 2013:
  • Amie Brooks
  • Kenton Brown
  • Jennifer Clements
  • Andria Eker
  • Christa George
  • Craig Logemann
  • Joel Marrs
  • Melissa Murfin
  • Sean Stewart
  • Yuliana Toderika
  • Jonathan White

 

• The Endocrine and Metabolism PRN has more than 290 members and represents a diverse group of clinical pharmacists dedicated to advancing clinical practice, teaching, and research. The Endocrine and Metabolism PRN would like to welcome the newest members of the group:

• Ashley Butler
• Yuliya Byakina
• Lauren Chambers
• Elena Coppol
• Sharon Edmondson
• Alysha Fahmi
• Olubukola Fakunie-Adeyemi
• Christy Gaddy
• Anthony Hager
• Natalie Hanson
• I. Kuan Hsu
• Sanaullah Mehridel
• Joseph Merkel
• Justin Meyer
• Suzanne Molino
• Rachel Perry
• Rachel Roberts
• Jonathan Schultz
• Sean Stewart
• Elizabeth Stone
• Anne-Claire Thomas

 

Resident Travel Scholarship

The Endocrine and Metabolism PRN Residency Travel Scholarship is intended to provide financial support for a resident-level member to the annual or Updates in  Therapeutics  ACCP meeting. The applicant must be a resident member (PGY1 or PGY2) of the ACCP Endocrine and Metabolism PRN. The applicant must provide a statement on why he or she is involved with the Endocrine and Metabolism PRN and how attending the meeting will assist in the applicant’s career and/or residency goals. A current copy of the applicant’s CV, highlighting professional organizations and community service, with one letter of recommendation are required for complete application.

Congratulations to Dr. Shubha Bhat, a PGY2 ambulatory care resident at the University of Illinois at Chicago, who will receive the ACCP Endocrine and Metabolism PRN Resident Scholarship. She will receive $500 to attend the ACCP Updates in Therapeutics^® meeting in Rosemont, Illinois.

 

Monthly Online Journal Club

The Communications Committee continues to lead the PRN in the monthly online journal club on our PRN e-mail list. The online journal club was implemented in February 2010. The purpose of the online journal club is to provide an awareness of key articles that add new information to the fields of endocrinology and metabolism. Members of the PRN are asked to contribute articles and comments to foster active discussion periodically. Active members from the Communications Committee have been soliciting journal club articles from the PRN e-mail list and have been posting one or two articles every month. The following members have been involved in continuing the monthly online journal club: Lisa Chastain (Communications Committee chair), Ben Gross (member), Richard Hess (member), Robin Koffarnus (member), Molly Minze (member), Sara “Mandy” Reece (member), Christie Schumacher (member), and Linda Thomas (member). Please contact Lisa Chastain, [email protected], for more information about the online journal club.

Publications:

Ann Marie Nye

Nye A. “Why I Am an AGS Member” for the American Geriatrics Society Newsletter 2013;44:6.

Nye A, Hamrick I, Rauch A, Pound M, Shelton P. Calcium supplementation documentation in conjunction with oral bisphosphonate use. Consult Pharm 2013;28:31-8.

Spivey J, Nye AM. Bullous pemphigoid: corticosteroid treatment and adverse effects in long-term care patients. Consult Pharm 2013;28:452-9.

 

Mary Beth O’Connell

Afonso N, Mendez J, O’Connell MB, Bugdalski-Stutrud CA, Smith GB, Waites C, Bowers C, Bruer S. Experiential interprofessional education using an older adult home visit. Med Sci Educ 2013;23:583-6.

 

Jeannie Lee

Gilligan AM, Loui JA, Mezdo A, Patel N, Lee JK.* Geriatric quality-of-life: a comparison of active older individuals and pharmacy student perceptions. Am J Pharm Educ 2014;78:Article 10.

Lee JK, D’Huyvetter K. Elder Care – A Resource for Interprofessional Providers: Sleep in Older Adults – Pharmacotherapy. POGOe – The Portal of Geriatrics Online Education, 2013. Available at www.pogoe.org/productid/21712.

Lee JK, Tang DH, Mollon L, Armstrong EP. Cost-effectiveness of biological agents used in ulcerative colitis. Best Pract Res Clin Gastroenterol 2013;27:949-60.

Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant 2013;13:2364-73.

Lee JK, Slack MK, Martin J, Ehrman C, Chisholm-Burns MA. Geriatric patient care by U.S. pharmacists in healthcare teams: systematic review and meta-analyses. J Am Geriatr Soc 2013;61:1119-27.

Tang DH, Harrington AR, Lee JK, Lin M, Armstrong EP. Systematic review: economic studies on biological agents used to treat Crohn’s disease. Inflamm Bowel Dis 2013;19:2673-94.

Burgin LB, Gamboa AM, Tierney DM, Lee JK.* Interactive approach by pharmacy students to educate older adults on the safe use of over-the-counter medications. Consult Pharm 2013;28:168-75.

*Corresponding author.

 

Scott Vouri

Cantrell MA, Baye Jordan, Vouri SM. Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasia. Pharmacotherapy 2013;33:639-49.

Cantrell MA, Vouri SM. Benign prostatic hyperplasia. In: Murphy JE, Lee MW, eds. Pharmacotherapy Self-Assessment Program, 2013 Book 1. Special Populations. Lenexa, KS: American College of Clinical Pharmacy, 2013:21-34.

Kebodeaux CD, Wilson AG, Smith D, Vouri SM. A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV. HIV AIDS (Auckl) 2013;5:263-74.

Vouri SM, Blaszczyk AT. Bisphosphonate use in patient undergoing hemodialysis. Consult Pharm 2013;28:738-41.

Vouri SM, Grice GR, Roberts A, Berry T, Duncan W. Didactic and experiential interprofessional, inter-institutional courses at a private college of pharmacy. Curr Pharm Teach Learn 2013;5:626-31.

Vouri SM, Marcum ZA. Use of a medication reconciliation tool in an outpatient geriatric clinic. J Am Pharm Assoc 2013;53:652-8.

 

New ACCP Fellow:

J. Mark Ruscin, Pharm.D., FCCP, BCPS: Professor and chair, Department of Pharmacy Practice, SIU Edwardsville School of Pharmacy.

 

Awards:

Jeannie Lee: Excellence in Geriatric Pharmacy Practice, Commission for Certification in Geriatric Pharmacy. Jeannie Lee also received the Clinical Sciences Educator of the Year Award, University of Arizona College of Pharmacy.

Mary Beth O’Connell: Building Michigan’s Health Care Workforce Award for Interprofessional Teamwork Initiative; Michigan Health Council.

 

Grants:

Jeannie Lee:

Title: Chronic Disease Health Beliefs, Medication Adherence, and Health Literacy

Source: NIH – NHLBI

Goal: To quantitatively assess medication adherence among patients with chronic disease, explore the impact of chronic disease health beliefs and health literacy on medication adherence, and develop recommendations for primary care providers to improve medication adherence

Role: Co-I (PI, Susan Shaw, Anthropology)

Amount: $1,480,000

% Effort: 15%

 

Title: Pima County AAPI Exchange Navigator Program

Source: Health and Human Services

Goal: To reduce the number of Asian American and Pacific Islanders (AAPIs) uninsured in Pima County by establishing the Exchange Navigator to educate and enroll AAPI individuals and families into Marketplace-qualified health plans

Role: Co-I (PI, Howard Eng, COPH)

Amount: $190,268

% Effort: 5%

 

Title: iForum Rx – An Online Journal Club for Ambulatory Care Practitioners

Source: American College of Clinical Pharmacy (ACCP)

Goal: To redesign iForumRx.org, an interactive Web-based community designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence, to empower practitioners to apply the best evidence to patient care in ambulatory care settings

Role: Co-I (PI, Stuart Haines, Pharm.D.)

Amount: $2000

% Effort: 2%

 

Title: Arizona Geriatric Education Center (UB4HP1904)

Source: Department of Health and Human Services, Health Resources and Services Administration

Goal: To train health professionals throughout the state in the care of older adults

Role: Co-I and member of interprofessional geriatric scholars; providing clinical pharmacy expertise and education related to pharmacology in aging, pharmacotherapy, and medication management and adherence (PI, Mindy Fain and Jane Mohlar, ACOA)

Amount: $2,100,000

% Effort: 9%

Date: July 2012 – Present

 

Other Notable Achievements:

Lisa C. Hutchison: Received a Josiah Macy Jr. Foundation Interprofessional Education Collaborative Development Award for an interprofessional simulation she wrote with colleagues from the University of Arkansas for Medical Sciences titled “Saving Red’s Toe: Fostering Interprofessional Collaboration in Assessment and Care Planning.” Lisa C. Hutchison was also named a member of the writing panel for the American Geriatrics Society (AGS) Geriatrics-for-Specialists Initiative Clinical Practice Guideline on Delirium. She is working with an interprofessional panel to develop guidelines for the prevention and treatment of postoperative delirium in older adults. The panel is supported by AGS and the John A. Hartford Foundation. Presentation of their work is anticipated at the October 2014 meeting of the American College of Sur.

Jeannie Lee: Became a fellow of the American Society of Health-System Pharmacists, 2013.

Leslie Richard: Received BCPS and CGP certification.

Introduction:

The GILN PRN would like to ask all interested ACCP members to stop by our networking table at the spring ACCP meeting.

Awards:

Guy-Armel Bounda, Ph.D.(c), M.Sc., B.Sc.: Awarded the International Forum Student Scholarship for the 2014 International Forum on Quality and Safety in Healthcare, sponsored by The Institute of Healthcare Improvement Open School and the British Medical Journal.

Eric H. Frankel, Pharm.D., MSE, BCNSP, and the Metabolic Support Service at Truman Medical Center in Kansas City: Recently awarded the Clinical Nutrition Team of Distinction Award from A.S.P.E.N. This award recognizes excellence in interdisciplinary clinical nutrition practice. The award is designed to identify and elevate the stature of interdisciplinary nutrition care within institutions and agencies and within communities. Clinical nutrition teams, as defined for this award, consist of an identified interdisciplinary group of practitioners with a member from each of four disciplines: dietetics, medicine, nursing, and pharmacy.

Publications:

1. Bounda GA. Integration of faith and pharmacy: a smile that strengthened faith of a heart surgery patient. Christ Pharm 2013;16:6-9.
2. Bounda GA, Ngarambe C, Wei Hong G, Feng Y. Assessment and evaluation of efficacy of a clinical pharmacist-led inpatient warfarin knowledge education program and follow up at a Chinese tertiary referral teaching hospital. Arch Pharm Pract 2013;4:168-79.
3. Bounda GA, Ngarambe C, Wei Hong G, Feng Y. Analysis and comparison of two low warfarin regimens in Chinese patients. J Chin Pharm Sci 2013;22:95-100.
4. Bounda GA, Ngarambe C, Wei Hong G, Feng Y. Key components to consider when developing an anticoagulation clinic—a pharmacy teaching and training approach: literature review. Pharm Educ 2013;13:61-9.
5. Bounda GA, Zhi Hui H, Wei Hong G, Feng Y. Assessment of enoxaparin anti-Xa activity and treatment efficacy’s evaluation. Int J Pharm Teach Pract 2013;4:511-5.
6. Bounda GA, Zhi Hui H, Wei Hong G, Feng Y. Assessment of enoxaparin anti-Xa activity and treatment efficacy’s evaluation [abstract]. Pharmacotherapy 2013;33:e57.
7. Kale-Pradhan PB, Zhao JJ, Palmer JR, Wilhelm SM. The role of antimicrobials in Crohn’s disease. Expert Rev Gastroenterol Hepatol 2013;7:281-8. Review.
8. Lipari M, Benipal H, Kale-Pradhan P. Roflumilast in the management of chronic obstructive pulmonary disease. Am J Health Syst Pharm 2013;70:2087-95.
9. McMahon MM, Nystrom EM, Braunschweig C, Miles JM, Compher C. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. J Parenter Enteral Nutr 2013;37:23-36.
10. Seifert CF, Wiltrout TR. Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors. Clin Ther 2013;35:1412-7.
11. Vilella AL, Seifert CF. Timing and appropriateness of initial antibiotic therapy in newly presenting septic patients. Am J Emerg Med 2014;32:7-13.
12. Wilhelm SM, Rjater RG, Kale-Pradhan PB. Perils and pitfalls of long-term effects of proton pump inhibitors. Expert Rev Clin Pharmacol 2013;6:443-51.

Other Notable Achievements:

Devada Singh-Franco, Pharm.D.: Became a Certified Diabetes Educator and was a contributor to the Medscape Ask-the-Expert article “GI Injury: Common with New Antiplatelets and Anticoagulants?” Medscape. December 26, 2013.

April Smith, Pharm.D., BCPS: An invited speaker at Obesity Week 2013 (national convention of the American Society for Metabolic & Bariatric Surgery and The Obesity Society); November 2013; Atlanta, GA. Presentation: “Pharmacology: Help or Hindrance?”

Wiseman A, Sanghavi K, Brunstein C, Warlick E, Weisdorf D, Cao Q, Rogosheske J, Jacobson P. Phosphoramide mustard as a biomarker of cyclophosphamide exposure in adults receiving allogeneic reduced intensity conditioning hematopoietic cell transplantation. Blood 2013;122:5461. Abstract 721.

Sanghavi K, Jacobson PA, Brundage R, Kirstein M. Population pharmacokinetics of fludarabine in nonmyeloablative hematopoietic stem cell transplantation patients. Presented at: American Society of Clinical Pharmacology and Therapeutics; March 21, 2014; Atlanta, GA. 2014 Clinical Pharmacology and Therapeutics. Abstract 317.

 

Ninh (Irene) M. La-Beck, Pharm.D.

Caron W, Lay JC, Fong A, La-Beck NM, Kumar P, Newman S, Zamboni BA, Crona D, Clarke-Pearson D, Brewster W, Van Le L, Bae-Jump V, Gehrig P, Zamboni WC. Translational studies of phenotypic probes for the mononuclear phagocyte system and liposomal pharmacology. J Pharmacol Exp Ther 2013;347:599-606. (Impact factor 6.846)

Gibson JM, Alzghari S, Ahn C, Trantham H, La-Beck NM.* The role of pegylated liposomal doxorubicin in ovarian cancer: a meta-analysis of randomized clinical trials. Oncologist 2013;18:1022-31. (Impact factor 4.095.) Featured on F1000 Prime and MDLynx.

 

Jacky Olin, Pharm.D., M.S., BCPS

Olin JL, Williams SW, Dirks-Naylor AJ. Omacetaxine mepesuccinate: a novel mRNA translation inhibitor for drug-resistant chronic myelogenous leukemia. J Hematol Oncol Pharm 2013;3:112-20.

 

Jai N. Patel, Pharm.D.

Gillis N, Patel JN, Innocenti F. Clinical implementation of germline cancer pharmacogenetic variants during the next-generation sequencing era. Clin Pharmacol Ther 2014;95:269-80.

Patel JN. Application of genotype guided cancer therapy in solid tumors. Pharmacogenomics 2014;15:79-93.

 

Christine Walko, Pharm.D., BCOP

Brewer NT, Defrank JT, Chiu WK, Ibrahim JG, Walko CM, Rubin P, Olajide OA, Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Peppercorn JM, McLeod HL, Carey LA, Irvin WJ. Patients’ understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer. Public Health Genomics 2014;17:43-7.

Keating K, Walko CM, Stephenson B, O’Neil BH, Weiss J. Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital. J Oncol Pharm Pract 2013. [Epub ahead of print]

*Corresponding author.

 

New ACCP Fellow:

Pamala Jacobson, Pharm.D.

 

Other Notable Achievements:

Clarissa Havel, Pharm.D., BCPS: Attended, and achieved a certificate of completion from, the Northwestern Memorial Healthcare 16th Annual Oncology Nursing Conference, “Keeping Up with Cancer,” on November 22, 2013, at Northwestern Memorial Hospital in Chicago, Illinois. Throughout the year, she has participated successfully in the Northwestern CME lecture series on gastrointestinal tumors.

Bonnie A. Labdi, Pharm.D.: Will serve as chairperson for the 2014–2015 HOPA Publications Committee.

Jai N. Patel, Pharm.D.: Now the chief of pharmacology research, phase I trials, at the Levine Cancer Institute (Carolinas HealthCare System) in Charlotte, North Carolina.

Scott Soefje, Pharm.D., MBA, BCOP: Chosen as president-elect of HOPA for 2014–2015.

Christine Walko, Pharm.D., BCOP: Now the clinical pharmacogenomics scientist in the new Personalized Medicine Institute at Moffitt Cancer Center, where she also serves as the cochair of the Clinical Genomics Action Committee. She is a member of the Task Force on Oral Cytotoxic Chemotherapy Dosing in the Elderly for the International Society of Geriatric Oncology (SIOG).

Introduction:

The Immunology/Transplantation PRN has grown to more than 425 members! We encourage all members to get involved and to be sure to provide us with suggestions and comments to make our PRN even better.

Promotions:

None reported.

Awards:

None reported.

Grants:

None reported.

Publications: We would like congratulate the following PRN members on their publications during the past several months.

1. Alkhatib AA, Maldonado AQ, Abdel JA, Hutson W. Physicians’ attitude toward organ donation and transplantation in the USA. Clin Transplant 2014;28:149-51.
2. Bloom RD, Trofe-Clark J, Wiland A, Alloway RR. A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients. Clin Transplant 2013;27:E685-93.
3. Doligalski CT, Verbosky M, Alexander E, Kotis D, Powell M. Practice management training in the PGY1 residency year: best practices from two nationwide surveys. Hosp Pharm 2014;49(3).
4. Ensor C, Doligalski CT. Proliferation signal inhibitor toxicities after thoracic transplantation. Expert Opin Drug Metab Toxicol 2013;9:63-77.
5. Everly MJ, Rebellato LM, Haisch CE, Briley KP, Bolin P, Kendrick WT, Kendrick SA, Morgan C, Maldonado AQ, Harland RC, Terasaki PI. Impact of IgM and IgG3 anti-HLA antibodies in primary renal allograft recipients. Transplantation 2014. In press.
6. Gaber LW, Knight RJ, Patel SJ. A surgeons’ guide to renal transplant immunopathology, immunology, and immunosuppression. Surg Clin North Am 2013;93:1293-307.
7. Gaurav G, Abu Jawdeh BG, Racusen LC, Bhasin B, Arend LJ, Trollinger B, Kraus E, Rabb H, Zachary AA, Montgomery RA, Alachkar NA. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Transplantation. Accepted for publication.
8. Jantz AS, Patel SJ, Suki WN, Knight RJ, Bhimiraj A, Gaber AO. Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients. Case Rep Transplant 2013 Jun 13. [Epub ahead of print]
9. Maldonado AQ, Bitterman AN, Ojogho ON, Bowen KA, Weeks DL. Efficacy of valganciclovir plus cytomegalovirus immune globulin for prevention of cytomegalovirus disease in high risk renal transplant recipients. Ann Pharmacother 2014. In press.
10. Martin ST, Powell JT, Patel M, Tsapepas DS. Risk of posttransplant lymphoproliferative disorder associated with use of belatacept. Am J Health Syst Pharm 2013;70:1977-83.
11. Moten MA, Gaber AO, Putney D, Patel SJ. Low-molecular-weight heparin dosing and monitoring in solid organ transplant recipients. Clin Transplant 2013;27:852-7.
12. Moten MM, Doligalski XR. Post-operative transplant immunosuppression in the critical care unit. AACN Adv Crit Care 2013;24:345-52.
13. Patel SJ, Devos JM, Knight RJ, Dawson KL, Suki WN, Gonzalez JM, Abdellatif AA, Gaber AO. Effects of rituximab on the development of viral and fungal infections in renal transplant recipients. ISRN Transplant 2013;2013:Article 819025.
14. Powell JT, Tsapepas DS, Martin ST, Hardy MA, Ratner LE. Managing renal transplant ischemia reperfusion injury: novel agents in the pipeline. Clin Transplant 2013;27:484-91.
15. Sammons CS, Doligalski CT. The utility of procalcitonin as a biomarker in lung transplant recipients. Ann Pharmacother 2014;48:116-22.
16. Shah S, Tsapepas DS, Kubin CJ, Martin ST, Mohan S, Ratner LE, Pereira M, Kapur S, Dadhania DM, Walker-McDermott JK. Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation. Transpl Infect Dis 2013;15:502-9.
17. Tichy EM, Pilch NA, Smith LD, Maldonado AQ, Taber DJ. The transplant pharmacy practice model: building a business plan to support the practice. Am J Health Syst Pharm 2014. In press.
18. Tsapepas DS, Powell JT, Martin ST, Hardy MA, Ratner LE. An update to managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline. Clin Transplant 2013;27:647-8.
19. Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube GK, Crew RJ, Ratner LE, Cohen DJ, Mohan S. Donor-specific antibodies should not preclude repeat renal transplantation. Transplantation 2013. [Epub ahead of print]

 

New ACCP Fellows:

Tiffany Kaiser, Pharm.D., BCPS; University of Cincinnati Medical Center, Cincinnati, OH.

Eric Tichy, Pharm.D., BCPS; Yale-New Haven Hospital, New Haven, CT.

Jennifer Trofe-Clark, Pharm.D., BCPS; Hospital of the University of Pennsylvania, Philadelphia, PA.

 

Other Notable Achievements:

Samir J. Patel: Wrote the “Care of the Kidney Transplant Recipient” chapter in PSAP 2014 Book 1 (Critical and Urgent Care).

Jennifer Trofe-Clark: Successfully recertified for BCPS in Pharmacotherapy in 2014.

 

Other:

The Hospital of the University of Pennsylvania has accepted Daniel R. Stevens for a 1-year renal transplant pharmacy fellowship for 2014–2015. This is a new position for the institution.

Introduction:

The ID-PRN, with more than 1900 members, including 575 trainees, continues to be one of the largest PRNs. The ID-PRN membership has experienced a 69% increase during a 5-year period. The ID-PRN e-mail list continues to serve as a vast resource for the exchange of ID-related knowledge and ideas. Regarding research and scholarly activity, we are looking forward to providing two scholarships to the 2014 Focused Investigator Training (FIT) Program.

 

Promotions:

Christopher Frei: Became a division head of the Pharmacotherapy Division (UT Austin College of Pharmacy) and director for the Pharmacotherapy Education and Research Center (UTHSC San Antonio School of Medicine).

Krista Gens: Became the PGY1 residency program director at North Memorial Medical Center Robbinsdale, MN.

Aileen Martinez: Accepted a position as an infectious disease specialist at Martin Health System after completing a PGY2 residency in infectious diseases at Lee Memorial Health System

Diane Rhee: Promoted to an associate professor of pharmacy practice at Roseman University of Health Sciences.

Katie Suda: Accepted a position as a research health scientist with the Department of Veterans Affairs Center of Innovation for Complex Chronic Healthcare.

Niyati Vakil: Accepted a position as an antibiotic utilization review and stewardship pharmacist at Cedars-Sinai Medical Center.

 

Awards:

Scott Bergman: Received the New Practitioner Leadership Award from the Illinois Council of Health-System Pharmacists for 2013.

Kimberly Lee: Received the Virginia Society of Health-System Pharmacists Clinical Pharmacy Achievement Award.

Christina Madison: Received Honorable Mention: Pharmacy Today One to One Patient Counseling Recognition Program (2014) sponsored by the American Pharmacists Association (APhA) (one of only 20 pharmacists in the country who received the award); received the Southern Nevada Immunization & Health Coalition (SNIHC) Silver Syringe Award – 2013 Immunization Education Champion of the Year.

Katherine Perez: Received the ASHP Foundation Innovation in Pharmacy Practice Award for 2013 – Integrating Rapid Pathogen Identification and Antimicrobial Stewardship Significantly Decreases Hospital Costs.

Katie Suda: Received the Drake University Alumni Achievement Award.

Eman Younis: Received a letter of appreciation/commendation from the World Health Organization (WHO) for participating in a national campaign on hand hygiene in the WHO global annual campaign on hand hygiene (SAVE Lives: Clean Your Hands).

 

Grants:

Christopher Frei: A coinvestigator on the National Library of Medicine (NLM) and National Institutes of Health (NIH) National Network of Libraries of Medicine (NN/LM), South Central Region (SCR) CTSA Community Engagement Award for “What Is CA-MRSA? (PA Seger, Principal Investigator).

Debbie Goff: Received a grant in collaboration with the Federation of Infectious Diseases Societies of South Africa to start an antimicrobial stewardship mentoring program between OSU-ASP (The Ohio State University Antimicrobial Stewardship Program) pharmacists and South African pharmacists.

 

Publications:

Aitken SL, Palmer HR, Topal JE, Gabardi S, Tichy E. Call for antimicrobial stewardship in solid organ transplantation. Am J Transplant 2013;13:2499.

Altshuler J, Aitken SL, Guervil D, Esaian D, Papadopoulos J, Arias CA. Treatment of extended-spectrum beta-lactamase Enterobacteriaceae with cefepime: the dose matters, too. Clin Infect Dis 2013;57:915-6.

Barriere SL. The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia. Future Microbiol 2014 Jan 22. [Epub ahead of print]

Berg ML, Estes LE, Dierkhising RA, Curran B, Enzler MJ. Evaluation of impact of statin use on CPK elevation during daptomycin therapy. Ann Pharmacother 2014;48:320-7.

Beyda ND, Alam MJ, Garey KW. Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis 2013;77:324-6.

Bookstaver DA, Bland CM, Mansell KA. Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates. J Med Microbiol 2014;63:218-21.

Bookstaver PB, Rokas KE, Norris LB, Edwards JM, Sherertz RJ. Stability and compatibility of antimicrobial lock solutions. Am J Health Syst Pharm 2013;70:2185-98.

Bosch K, McLaughlin M, Esterly JS, Rhodes NJ, Postelnick MJ, Scheetz MH. Impact of vancomycin treatment duration and dose on kidney injury. Int J Antimicrob Agents 2013 Dec 7. [Epub ahead of print]

Bowers DR, Hunter AS, Jacobs DM, Kuper KM, Musick WL, Perez KK, Shah DN, Schilling AN. Significant publications on infectious diseases pharmacotherapy in 2012. Am J Health Syst Pharm 2013;70:1930-40.

Chahine EB, Karaoui LR, Mansour H. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann Pharmacother 2014;48:107-15.

Corey GR, Kollef MH, Shorr AF, Rubinstein E, Stryjewski ME, Hopkins A, Barriere SL. Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival. Antimicrob Agents Chemother 2014 Jan 13. [Epub ahead of print]

Daniels KR, Lee GC, Frei CR. Trends in catheter-associated urinary tract infections among a national cohort of hospitalized adults, 2001-2010. Am J Infect Control 2014;42:17-22.

Darkoh C, Turnwald BP, Koo HL, Garey KW, Jiang ZD, Aitken SL, Dupont HL. Colonic immunopathogenesis of Clostridium difficile infections. Clin Vaccine Immunol 2014 Jan 29. [Epub ahead of print]

Date AA, Shibata A, McMullen E, La Bruzzo K, Bruck P, Belshan M, Zhao Y, Destache CJ. Thermosensitive gel containing cellulose acetate phthalate-efavirenz nanoparticles for prevention of HIV-1 infection. J Biomed Nanotech 2014. In press.

Denetclaw TH, Dowling TC, Steinke D. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients. Ann Pharmacother 2013;47:1611-7.

Duane TM, Zuo JX, Wolfe LG, Bearman G, Edmond MB, Lee K, Cooksey L, Stevens MP. Surgeons do not listen: evaluation of compliance with antimicrobial stewardship program recommendations. Am Surg 2013;79:1269-72.

Esterly JS, McLaughlin MM, Malczynski M, Qi C, Zembower TR, Scheetz MH. Pathogenicity of clinical Acinetobacter baumannii isolates in a Galleria mellonella host model according to blaOXA-40 gene and epidemiological outbreak status. Antimicrob Agents Chemother 2014;58:1240-2.

Fleming E, Heil EL, Hynicka LM. Treatment strategy for a multi-drug resistant Klebsiella UTI: a case report. Ann Pharmacother 2014;48:123-7.

Gens KD, Elashboury RH, Holt JS. Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection. J Pharm Pract 2013;26:498-505.

Goff DA, Hawksworth K, Mangino JM. Evaluation of an app: STAB-IT™ Staphylococcus aureus bacteremia is terrible. J Mobile Tech Med 2013;2:15-20.

Goff DA, Nicolau D. When pharmacodynamics trump costs: an antimicrobial stewardship program’s approach to selecting optimal antimicrobial agents. Clin Ther 2013;35:766-71.

Hirsch EB, Chang KT, Zucchi PC, Francoeur DN, Ledesma KR, Tam VH, Lasco TM. An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae. J Infect Chemother. Accepted for publication.

Johnson CS, Frei CR, Metersky ML, Anzueto AR, Mortensen EM. Non-invasive mechanical ventilation and mortality in elderly immunocompromised patients hospitalized with pneumonia: a retrospective cohort study. BMC Pulm Med 2014;14:7.3.

King ST, Dillon ER, Cannon CG, Finley RW. Daptomycin-induced rhabdomyolysis and acute liver injury. Scand J Infect Dis. Accepted for publication.

King ST, Stover KR. Considering confounders of the galactomannan index: the role of piperacillin-tazobactam. Clin Infect Dis 2014;58:751-2.

Labreche MJ, Lee GC, Attridge RT, Mortensen EM, Koeller J, Du LC, Nyren NR, Treviño LB, Treviño SB, Peña J, Mann MW, Muñoz A, Marcos Y, Rocha G, Koretsky S, Esparza S, Finnie M, Dallas SD, Parchman ML, Frei CR. Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med 2013;26:508-17.

McLaughlin M, Advincula MR, Malczynski M, Barajas M, Qi C, Scheetz MH. Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes. BMC Infect Dis 2014;14:31.

Memoli D, Shepardson A, Joshi M, Heil E. Reducing daptomycin expenditures by standardizing doses. Am J Health Syst Pharm 2014;71:12-4.

Monteen MR, Ponnapula S, Wood GC, Croce MA, Swanson JM, Boucher BA, Fabian TC. Treatment of Chryseobacterium indologenes ventilator-associated pneumonia in a critically ill trauma patient: a case report. Ann Pharmacother 2013;47:1736-9.

Nevrekar S, Cunningham KC, Greathouse KM, Panos NG. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase–producing Klebsiella pneumoniae ventriculitis. Ann Pharmacother 2014;48:274-8.

Olsen KM, Gross AE, DiPiro JT. Intra-abdominal infections. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach, 9th ed. New York: McGraw-Hill, 2014:1821-34.

Ponnapula S, Swanson JM, Wood GC, Boucher BA, Wells DL, Croce MA, Fabian TC. Treatment of Rhizobium radiobacter bacteremia in a critically ill trauma patient. Ann Pharmacother 2013;47:1584-7.

Reed E, West J, Keating E, Pancholi P, Balada-Llsat J, Mangino J, Bauer K, Goff DA. Improving the management of candidemia through antimicrobial stewardship interventions. Diagn Microbiol Infect Dis 2014;78:157-61.

Stitely M, Sweet M, Slain D, Alons L, Holls C, Hochberg C, Briggs F. Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery receiving two differing doses of pre-operative cefazolin. Surg Infect 2013;14:455-9.

Stover KR, King ST, Cleary JD. Cardiac toxicity of the echinocandins: chance or cause and effect association? J Clin Pharm Ther 2014;39:1-3.

Suda KJ, Greene J, Shelton CM. Geographic location of antiretroviral clinical trials in HIV infected pediatric patients. Int J Clin Pharm 2013;6:1203-7.

Talwani R, Heil EL, Gilliam B, Temesgen Z. Simeprevir: a macrocyclic HCV protease inhibitor. Drugs Today 2013;49:769-79.

Torres A, Rubinstein E, Corey GR, Stryjewski ME, Barriere SL. Analysis of phase 3 telavancin nosocomial pneumonia data excluding patients with severe renal impairment and acute renal failure. J Antimicrob Chemother 2014 Jan 6. [Epub ahead of print]

Varughese CA, Vakil NH, Phillips KM. Antibiotic-associated diarrhea: a refresher on causes and possible prevention with probiotics – a continuing education article. J Pharm Pract 2013;26:476-82.

Wilde AM, Gross AE. A new practitioner’s guide to antimicrobial stewardship. Am J Health Syst Pharm 2013;70:2180-3.

Wiskirchen DE, Nordmann P, Crandon JL, Nicolau DP. In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1 producing Enterobacteriaceae. Antimicrob Agents Chemother 2014;58:1671-7.

Wiskirchen DE, Nordmann P, Crandon JL, Nicolau DP. Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing the OXA-48 carbapenemase in a murine infection model. Antimicrob Agents Chemother 2014;58:1678-83.

Zeuli JD, Wilson JW, Estes LE. The effect of combination fluoroquinolone and azole use on qt prolongation in hematology patients. Antimicrob Agents Chemother 2013;57:1121-7.

 

New ACCP Fellows:

Christopher R. Frei, Pharm.D., M.Sc., FCCP, BCPS; San Antonio, TX.

Jason Gallagher, Pharm.D., FCCP, BCPS; Philadelphia, PA.

Vanthida Huang, Pharm.D., FCCP, BSPHM; Atlanta, GA.

 

Other Notable Achievements:

Melody Berg, Emily Heil, and Christina Madison: Became an American Academy of HIV Medicine (AAHIVM) AAHIVM HIV Pharmacist (AAHIVP).

Brandon Bookstaver: Elected as president of the South Carolina Society of Health-System Pharmacists.

Zhe Han, Aileen Martinez, and Marylee Worley: Became Board Certified Pharmacotherapy Specialists (BCPSs).

Sandra Nelson: Received a master’s degree (M.Sc.) in quality improvement and patient safety.

Rhonda Pohlman: Graduated with a Pharm.D. degree from Idaho State University’s nontraditional Pharm.D. program in December.

Colleen Terriff: Received an MPH degree in international medicine (awarded December 2013).

Mickala Thompson: Attained BCNSP certification.

Introduction:

The Nephrology PRN has been active in a broad range of activities this year. One major accomplishment is the PRN’s involvement in the Kidney Health Initiative (KHI). The KHI is an initiative developed by the U.S. Food and Drug Administration (FDA) and the American Society of Nephrology to advance the scientific understanding of the kidney health and patient safety implications of new and existing medical products. The KHI was also created to foster the development of therapies for diseases that affect the kidney by creating a collaborative environment in which the FDA and the greater nephrology community can interact to optimize the evaluation of drugs, devices, biologics, and food products. The ACCP Nephrology PRN will serve as a pioneer member of the KHI. Although many stakeholder groups are represented in the KHI, ours is the only pharmacy group.

 

Promotions:

• Abdulmalik Alkatheri, Pharm.D.: Promoted to associate professor of pharmacy practice, Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences.

 

Awards:

• Lori Wazny: Received the Canadian Society of Hospital Pharmacists National Award for Specialties in Pharmacy Practice. Awarded for “Cost Analysis of a Switch from IV to Subcut Epoetin Alfa in Patients Receiving Hemodialysis.”
• Lori Wazny: Received the Canadian Society of Hospital Pharmacists 2015 Manitoba Branch Award. Awarded for development of the Renal Pharmacist Performance Expectations (www.kidneyhealth.ca/wp/wp-content/uploads/pharmacy/Renal%20Pharmacist%20Performance%20Expectations.pdf).

 

Grant:

• Joanna Hudson: Received a grant award of $140,000 from the Oxnard Foundation to support her clinical research study titled “Development of Antibiotic Dosing Recommendations for Sustained Low Efficiency Dialysis.”

 

Publications:

• Alkatheri A. Urinary tract infections in Saudi renal transplant recipients. J Infect Dis Immun 2013;5:18-23.
• Alkatheri A. Stability of recombinant tissue plasminogen activator at –30°C over one year. Pharmaceuticals 2013;6:25-31.
• Alkatheri A, Albekairy A. Does the patients’ educational level and previous counseling affect their medication knowledge? Ann Thorac Med 2013;8:105-8.
• Alkatheri A, Alyousif S, Shabanah N, Bekairy AM, Harbi S, Hejaili F, Alkhadari A, Qandil A, Qandil A. Medication adherence among adult Saudi hemodialysis patients. Saudi J Kidney Dis Transplant. Accepted for publication.
• Cardone KE. End-stage kidney disease. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach, 9th ed. New York: McGraw-Hill, 2014. In press.
• Cardone KE, Grabe DW, Zasowski EJ, Lodise TP. Re-evaluation of ceftazidime dosing recommendations in patients on continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother.
• Chang Y, Burckart GJ, Lesko LJ, Dowling TC. Evaluation of hepatic impairment dosing recommendations in FDA-approved product labels. J Clin Pharmacol. 2013;53:962-6.
• Fordjour KN, Walton T, Doran JJ. Management of hyperkalemia in hospitalized patients. Am J Med Sci 2014;347:93-100.
• Harris LE, Reaves AB, Krauss AG, Griner J, Hudson JQ. Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis. Int J Pharm Pract 2013;21:55-61.
• Hudson JQ, Owens HM, Fleckenstein JF, Loveless VS, Hak LJ. Performance of methods to assess GFR in adults with liver disease. Renal Fail 2013;35:249-56.
• Joy MS, Frye RF, Nolin TD, Roberts BV, La MK, Wang J, Brouwer KL, Dooley MA, Falk RJ. In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases. Pharmacotherapy 2014;34:114-22.
• Joy MS, Roberts BV, Wang J, Hu Y, Hogan SL, Falk RJ. A pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis. Int J Clin Pharmacol Ther 2014 Feb 19. [Epub ahead of print]
• Ménard V, Lévesque E, Chen S, Eap O, Joy MS, Ekström L, Rane A, Guillemette C. Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer. Pharmacogenet Genomics 2013;23:684-96.
• Mindikoglu AL, Dowling TC, Weir MR, Seliger SL, Christenson RH, Magder LS. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology 2013 Jun 6. [Epub ahead of print]
• Moist L, Manns B, Soroka S, White C, Wazny L, Wilson J, Sood M, Bass A, Harwood L, McPharlene P. Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for anemia. Am J Kidney Dis 2013;62:860-73.
• Raymond CB, Wazny LD, Sood AR. Renal pharmacist clinical standards of practice. Can J Hosp Pharm 2013;66:369-74.
• Roberts BV, Susano I, Gipson DS, Trachtman H, Joy MS. Contribution of renal and non-renal clearance on increased total clearance of adalimumab in glomerular disease. J Clin Pharmacol 2013;53:919-24.
• St. Peter W, Patel U, Wazny L. New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management. Curr Opin Nephrol Hypertens 2013;22:656-62.
• Soergel DG, Subach RA, Cowan CL, Violin JD, Lark MW. First clinical experience with TRV027: pharmacokinetics and pharmacodynamics in healthy volunteers. J Clin Pharmacol 2013;53:892-9.
• Soergel DG, Subach RA, Sadler B, Connell J, Marion AS, Cowan CL, Violin JD, Lark MW. First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers. J Clin Pharmacol 2014;54:351-7.
• Volpe DA, Tobin GA, Tavakkoli F, Dowling TC, Light PD, Parker RJ. Effect of uremic serum and uremic toxins on drug metabolism in human microsomes. Regul Toxicol Pharmacol 2014;68:297-303.
• Wang A, Nguyen T. New anticoagulation medications for atrial fibrillation. J Dev Drugs 2013;2:1000e123.
• Wazny LD, Raymond CB, Sood AR, Eng A, Verrelli M. Cost analysis of an intravenous to subcutaneous epoetin α conversion. Am J Nephrol 2013;38:496-500.
• Wong E, Nguyen T. A case-based approach to evaluating azithromycin use and cardiovascular risks. Consult Pharm 2014;29:47-52.
• Wong E, Nguyen T. Case study on zolpidem and new safety data. J Nurse Pract 2014;10:140-1.

 

 

Other Notable Achievements:

• Melanie S. Joy: Elected as a member of the Electorate Nominating Committee for the Pharmaceutical Sciences Section of the American Association for the Advancement of Science (AAAS).
• Amy Barton Pai: Invited to participate in the KDIGO Controversies Conference on the Management of Iron Therapy in CKD to be held in San Francisco, CA, March 27–30, 2014, and was selected to serve on the Programming Committee for the 2015 National Kidney Foundation’s spring clinical meeting.
• Wendy St. Peter and Joanna Hudson were selected to represent the Nephrology PRN in the KHI (described earlier), together with Katie Cardone (Nephrology PRN Chair) and Anne Marie Liles (PRN chair-elect).
• Ruth Ann Subach was directly involved in the design and conduct of all studies in which clinical data were reported in the S-1 document filed with the SEC.

Trevena, Inc., recently went public (www.trevenainc.com/news-details.php?id=63).

Introduction:

Members of the Pain and Palliative Care PRN continue to receive recognition for their accomplishments in publications, promotions, and other areas of achievement.

 

Promotion:

Farzana Musawwir: Promoted to critical care clinical pharmacist, University of Maryland, Baltimore Washington Medical Center, and continues to participate in various quality improvement initiatives.

 

Awards:

Jeffrey Fudin, Pharm.D.: Received American Academy of Pain Medicine’s (AAPM) Presidential Commendation, in recognition as “a voice for scientific integrity and an advocate for people in pain.” To be presented at: AAOPM Annual Meeting; March 8, 2014; Phoenix, AZ.

Jayne Pawasauskas, Pharm.D., BCPS: Received the 2013 Cardinal Health Generation Rx Award (for prescription drug abuse–related work).

Richard Wheeler, Pharm.D., BCPS: Received the 2013 Oklahoma Society of Health-System Pharmacists Pharmacist of the Year Award.

 

Publications:

Atkinson TJ, Cronin K, Jahn HL, Kubotera N, Rennick A, Fudin J. What’s new in NSAID pharmacotherapy? Pain Med 2013;14(suppl S1):S11–S17.

Atkinson TJ, Fudin J, Pandula A, Mirza M. Medication management in the elderly: unique and underutilized treatment options. Clin Ther 2013;34:1669-89.

Dole E, Fudin J. Pharmacists speak out: the AMA’s “drug store intrusion” resolution and Walgreens’ “good faith dispensing” policy. Drug Top 2013;157:9-10.

Donovan KJ, Fudin J. How changing hydrocodone scheduling will affect pain management. Pract Pain Manage 2013;13:69-74.

Fudin J. The hydrocodone question [In My View]. Drug Top 2013;157:14-6. (Also available online at http://drugtopics.modernmedicine.com/drug-topics/news/hydrocodone-question)

Fudin J, Atkinson TJ. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness [editorial]. Pain Med March 2014. In press.

Fudin J, Atkinson TJ. Opioid prescribing level off, but is less really more? Pain Med 2014. In press.

Fudin J, Fontenelle DV, Fudin HR, Carlyn C, Ashley CC, Hinden DA. Potential P-glycoprotein pharmacokinetic interaction of telaprevir with morphine or methadone. J Pain Palliat Care Pharmacother 2013;27:261-7.

Fudin J, Fontenelle DV, Payne A. Rifampin reduces oral morphine absorption; a case of transdermal buprenorphine selection based on morphine pharmacokinetics. J Pain Palliat Care Pharmacother 2012;26:362-7.

Kubotera N, Fudin J. Pain management for pharmacists – concepts and definitions. CE program at the University of Connecticut School of Pharmacy and Drug Topics. Drug Top 2013;April:52-61.

Sasu-Tenkoramaa J, Fudin J. Drug interactions in cancer patients requiring concomitant chemotherapy and analgesics. Pract Pain Manage 2013;13:50-64.

Sasu-Tenkoramaa J, Fudin J. Neuropathy in the cancer patient: causes and cures. Pract Pain Manage 2013;13:53-67.

Shaw K, Fudin J. Evaluation and comparison of online equianalgesic opioid dose conversion calculators. Pract Pain Manage 2013;13:61-6.

Younan M, Atkinson TJ, Fudin J. A practical approach to discontinuing NSAID therapy prior to a procedure. Pract Pain Manage 2013;13:45-51.

 

Textbook Chapters:

Atkinson TJ, Fudin J. The problem with chronic pain and opioid medications. In: Peppin J, Kirsh K, Coleman J, eds. Pain and Prescription Drug Diversion: Healthcare, Law Enforcement, and Policy Perspectives. Oxford University Press, 2013. Publication pending.

Fudin J, Shrivastava A, Atkinson TJ. Opioids for surgery or acute pain in patients on chronic buprenorphine. In: Aronoff G, ed. Medication Management of Chronic Pain: What You Need to Know. Trafford Publishing, 2013. Publication pending.

 

Other Notable Achievements:

Dennis VC, Britton ML, Carter SM, Wheeler RE. Improved examination performance after sequential introductory and advanced pharmacy practice experiences at the same institutional site. Poster Presentation 2013.

Fudin J: Blogs (posted at http://paindr.com/blog/, Fudin as owner and editor): Pain Chatter has close to 100 active blog posts that contain interactive communications with nationally recognized clinicians, public health specialists, law enforcement, and others.

Fudin J: Interviews in peer-reviewed and non–peer-reviewed journals, blogs. Countless articles published on and off the Internet, in professional journals, newspapers, newsletters, and so forth contain interviews with Dr. Fudin for various opinions. They are too numerous to list and do not include television or taped interviews. Some examples follow.

• Edlin M. New Bipartisan Bill Seeks to Reclassify Hydrocodone. April 15, 2013. (http://drugtopics.modernmedicine.com/drug-topics/news/drug-topics/fda/new-bipartisan-bill-seeks-reclassify-hydrocodone)
• Gallegos A. Physician Liability: When an Overdose Brings a Lawsuit. March 4, 2013. (www.ama-assn.org/amednews/2013/03/04/prsa0304.htm)
• The great hydrocodone rescheduling debate (Drs. Mary Lynn McPherson and Jeffrey Fudin, as published in Pharmacy Times and posted as sequential online interviews pre-MYCM 2013 conference. (www.pharmacytimes.com/search?get1=search&keywordTerm=pain+management)
• The last word on FDA opioid labeling? PROP, PROMPT still disagree; REMS revisions next. Pharmacy Practice News. October 2013;40. (www.pharmacypracticenews.com/ViewArticle.aspx?d=Policy&d_id=51&i=October+2013&i_id=1006&a_id=24268)
• PROP versus PROMPT: FDA speaks. Pract Pain Manage 2013;13:13-4.

Fudin J: Guideline development: February 21, 2014: Consultative meeting to provide feedback on draft guidelines for the proper use of urine testing in addiction medicine, hosted by the National Association of Addiction Treatment Providers (NAATP) with support from the Center for Lawful Access and Abuse Deterrence (CLAAD) and the American Society of Addiction Medicine (ASAM). Palm Beach Marriott; West Palm Beach, FL.

Musawwir F: Received Board Certification in Pharmacotherapy in 2013.

Robinson P: Opioids for older adults with chronic pain: new evidence, new questions. Presented at: American Geriatrics Society Symposium; May 14, 2014.

Stevens B, Pawasauskas J, Youssef R, Kelley M. Predictors of naloxone utilization in an adult inpatient population. Poster presented at: ASHP Midyear Clinical Meeting; December 2013; Las Vegas, NV.

Current Officers

Chair (2013–2014)	Bob John, Pharm.D., BCPS
Immediate Past Chair	Hanna Phan, Pharm.D., BCPS
Chair-Elect	Joseph LaRochelle, Pharm.D.
Secretary	Janie Robles, Pharm.D.

 

Collaboration Committee (Chair: Joseph LaRochelle)

The Collaboration Committee members have, starting at their in-person meeting during the ACCP Annual Meeting, developed an extensive plan for a manuscript tentatively titled “The Role of the Clinical Pharmacist in Pediatric Care.” The committee also held a meeting at the PPAG conference this year to discuss the work. This 18-member committee has outlined and divided out the sections of the paper and is currently writing and editing the extensive work. The paper will undergo a series of edits by experienced editors as well as a “blinded-review” process before being submitted to leading journals. It is hoped that the leading pharmacy and pediatric organizations support this document. The ultimate goal of this paper is to provide a scope of practice for pediatric pharmacists and to provide documentation for health care professionals and administration regarding  the utility of clinical pharmacists in the care of pediatric patients.

Education Committee (Chair: Christina Piro)

The committee successfully coordinated the Annual Meeting PRN focus session titled “Little Patients, Big Dilemmas.” This session will include updates on anticoagulation in pediatric patients and alternative drug therapy routes in the pediatric emergency department. The Education Committee continues to work on developing and submitting session proposals for the ACCP Annual Meeting each year. If you have any suggestions for future session topics, please contact the committee.

Nominations Committee (Chair: Tracy Hagemann)

We are continuing to encourage membership nominations for recognition within ACCP and candidates for office starting in fall 2014 (for chair-elect, 2-year term).

Student and Resident Committee (Chair: Chasity Shelton)

This committee is developing a survey to administer to student/resident/fellow members to determine their needs for this committee. The committee is planning to query the PRN members to develop a list of people interested in serving as a mentor to these student/resident/fellow members. Mentorship in this program would be informal (mostly to provide guidance and steer students in the right direction according to their interests and career goals; communication could be established and maintained by e-mail/telephone).

Travel Award Committee (Chair: Hanna Phan)

Two awards were offered for application in 2013. These awards were for resident and student Pediatric PRN members who were presenting (e.g., poster) at the 2013 ACCP Annual Meeting. Recipients of the award are recognized at the PRN annual business meeting, where recipients present their projects to those in attendance. This past year, we had one award recipient, Ms. K. Ashley Jones, a Pharm.D. Candidate (2014), from Auburn University. She presented her project, “The impact of acid suppression therapy on iron supplementation in the pediatric intensive care unit,” as part of our Pediatrics PRN annual business meeting in Albuquerque, New Mexico. We will once again be able to offer two travel awards for the 2014 ACCP Annual Meeting, and we have increased the amount of the award.

Research Committee (Chair: Varsha Bhatt-Mehta)

This is the first year for the Research Committee, which had several meetings to define the charges for the committee and to develop a charter, which is currently under review. The goal of the Pediatrics PRN PBRN is to work under the umbrella of this parent ACCP PBRN and perform practice-based, patient outcomes–oriented research using the talent within the PRN to further pediatric pharmacotherapy research and the goals of the ACCP PBRN by closely collaborating with it and supporting its activities.

 

Promotions:

None reported.

 

Award:

Lisa Lubsch: Received the Cardinal Glennon Children’s Medical Center Ambassador Choice Award.

Grants:

None reported.

 

Publications:

Lisa Lubsch: Guideline: Mogayzel PJ, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B; Pulmonary Clinical Practice Guidelines Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2013;187:680-9.

Bradley McCrory: Sherwin CMT, Zobell JT, Stockmann C, McCrory BE, Wisdom M, Young DC, Olson J, Ampofo K, Spigarelli MG. Pharmacokinetic and pharmacodynamic optimisation of intravenous tobramycin dosing among children with cystic fibrosis. J Pharmacokinet Pharmacodyn 2014;41:71-9.

 

New ACCP Fellows:

None reported.

 

Other Notable Achievements:

McCrory BE, Barclay CA, McPhail GL, Kirkendall ES, Downes KJ, Goldstein SL. Pharmacist screening for risk of acute kidney injury in the cystic fibrosis population. Paper presented at: 2013 North American Cystic Fibrosis Conference; October 17–19, 2013.

McCrory BE, Szczesniak RD, McPhail GL. Targeting higher vancomycin trough concentrations in patients with cystic fibrosis. Paper presented at: 2013 North American Cystic Fibrosis Conference; October 17–19, 2013.

McCrory, BE, Invited Presentation:Pediatric asthma. Presented to: Licensed Pharmacists as Part of MTM Training Lecture Series for CE, Cincinnati Health Department; August 8, 2013.

Introduction (recent activities, etc.):

The Pharmaceutical Industry PRN had a successful meeting at the ACCP Annual Meeting in Albuquerque on October 13, 2013, when new officers Sandra Chase (chair), Maggie Murphy (chair-elect), and Brian Simmons (secretary/treasurer) were sworn in. Rachel Couchenour is still providing excellent leadership as the PRN past chair. During the meeting, a discussion ensued with the PRN leadership team and other members regarding potential collaboration with the Rutgers Pharmaceutical Industry Fellowship Program with the hope of planning an educational event at the 2014 ACCP Annual Meeting for students and residents on career opportunities in the pharmaceutical industry. This project is ongoing and represents the first step in building a stronger partnership with new pharmacy graduates within the pharmaceutical and biotechnologic industries and our PRN. If you would like more information or have suggestions on how to bring students into the fold, please contact any of your PRN officers!

In addition, programming for the 2014 ACCP Annual Meeting by the Pharmaceutical Industry PRN will be on “The Drug Approval Process: Changes, Challenges, and How Clinical Pharmacists Can Get Involved.” This session will not only discuss changes in the drug development process, but also why drugs fail in late-stage development. These topics will then be incorporated into an interactive panel discussion with clinical pharmacists both in the pharmaceutical industry and in clinical practice regarding how we can work together to develop and conduct clinical trials. If you have any suggestions for potential speakers or if you would like to be involved, please contact officers Drs. Chase, Murphy or Simmons.

 

Promotion:

Rachel Couchenour, Pharm.D. (Pharmaceutical Industry PRN past chair): Promoted from director to senior director of medical affairs at Chelsea Therapeutics. Dr. Couchenour is based in Charlotte, North Carolina.

 

New ACCP Fellow:

Sandra Chase, Pharm.D., a medical science liaison with Otsuka Pharmaceuticals, was inducted as a Fellow of the American College of Clinical Pharmacy at the 2013 meeting in Albuquerque. Dr. Chase is also chair of the Pharmaceutical Industry PRN. Before joining Otsuka, Dr. Chase was a clinical pharmacist in cardiology with Spectrum Health System in Grand Rapids.

 

Other Notable Achievements:

Maggie Murphy, Pharm.D., chair-elect of the Pharmaceutical Industry PRN, recently took a medical science liaison position with The Medical Affairs Company/Takeda Pharmaceuticals and will be supporting the therapeutic area of IBD (inflammatory bowel disease). Dr. Murphy covers the Midwest.

Awards:

John E. Murphy, Pharm.D., FCCP, FASHP: Will receive the Harvey Whitney Lecture Award. The Harvey A.K. Whitney Lecture Award is given annually to an individual of high moral character, good citizenship, and elevated professional ideals. The recipient has made significant contributions to health-system pharmacy, including sustained exemplary service, an outstanding single achievement, or a combination of accomplishments benefiting the profession and public health.

Mary H.H. Ensom, Pharm.D., FCCP: Received the University of Kentucky 2013 Paul F. Parker Award in recognition of “an individual who has shown sustained contribution to the profession in practice, teaching or research; a commitment to high ideals and excellence in their chosen field; leadership and innovation; and a passion to encourage the personal and professional growth of others” (December 2013). In addition, Dr. Ensom received the 2014 Pharmacotherapy Best Practices Award (Merck) from the Canadian Society of Hospital Pharmacists (February 2014).

 

Grant:

Paul Beringer, Pharm.D., FCCP: Received a $192,377 grant from the Cystic Fibrosis Foundation for “Targeting CF Infection and Inflammation with Aerosolized Theta-defensin.”

 

Publications:

1. Cartwright AL, Wilby KJ, Corrigan S, Ensom MHH. Pharmacogenetics of risperidone: a systematic review of the clinical effects of CYP2D6 polymorphisms. Ann Pharmacother 2013;47:350-60.
2. Culley C, Kiang TKL, Gilchrist SE, Ensom MHH. Effect of the UGT1A1*28 allele on unconjugated hyperbilirubinemia in HIV patients receiving atazanavir: a systematic review. Ann Pharmacother 2013;47:561-72.
3. Ensom MHH, Kendrick J, Rudolph S, Decarie D. Stability of propranolol in extemporaneously compounded suspensions. Can J Hosp Pharm 2013;66:118-24.
4. Kendrick J, Ensom MHH, Steer A, White C, Kwan E, Carr RR. Standard-dose versus high-dose acyclovir in children treated empirically for encephalitis: a retrospective cohort study of its use and safety. Pediatr Drugs 2014 Feb 5. [Epub ahead of print]
5. Kiang TKL, Ng K, Ensom MHH. Multiple regression analysis of factors predicting mycophenolic acid free fraction in 91 adult organ transplant recipients. Ther Drug Monit 2013;35:867-71.
6. Kiang TKL, Wilby KJ, Ensom MHH. Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions. Clin Pharmacokinet 2013;52:487-510.
7. Kiang TKL, Wilby KJ, Ensom MHH. Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals. Clin Pharmacokinet 2014;53:141-53.
8. Kistner C, Ensom MHH, Decarie D, Lauder G, Carr RR. Compatibility of various naloxone hydrochloride concentrations with morphine sulphate in 0.9% sodium chloride injection. Can J Hosp Pharm 2013;66:163-70.
9. Ng K, Mabasa VH, Chow I, Ensom MHH. Systematic review of efficacy, pharmacokinetics and administration of intraventricular vancomycin in adults. Neurocrit Care. 2014;20:158-71.
10. Pawluk SA, Wilby KJ, Ensom MHH. Pharmacokinetic-profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children. Clin Pharmacokinet 2013;52:153-67.
11. Ramsey T, Lau TTY, Ensom MHH. Linezolid’s serotonergic and adrenergic drug interactions: a critical review and practical management approach. Ann Pharmacother 2013;47:543-60.
12. Tremblay S, Lau TTY, Ensom MHH. Vancomycin with rifampin for MRSA infections: what is the evidence? Ann Pharmacother 2013;47:1045-54.
13. Tuteja S, Duffy D, Dunbar RL, Movva R, Gadi R, Bloedon LT, Cuchel M. Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia. Pharmacotherapy 2014;34:227-39.
14. Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R. Community pharmacists’ attitudes towards pharmacogenetic testing. Per Med 2013;10:793-800.
15. Wilby KJ, Gilchrist SE, Ensom MHH. A review of the pharmacokinetic implications of schistosomiasis. Clin Pharmacokinet 2013;52:647-56.

Other:

Sony Tuteja, Pharm.D., M.S., BCPS: Appointed as the chair of the Organ Specific Diseases Scientific Section of Clinical Pharmacology & Therapeutics for 2014–2015.

Introduction

 

Publications:

The Women’s Health PRN published an opinion paper in Pharmacotherapy on the use of bioidentical hormones: Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2014 Jan 4. [Epub ahead of print]

A PRN opinion paper on the use of long-acting reversible contraceptives is expected to be published in Pharmacotherapy in the spring of 2014.

 

Jennifer McIntosh, Pharm.D., MHS

McIntosh J, Wahlin B, Grindlay K, Batchelder M, Grossman D. Insurance and access implications of an over-the-counter switch for a progestin-only pill. Perspect Sex Reprod Health 2013;45:164-9.

Gerald Briggs, BPharm, FCCP

• The 10th edition of his book, Drugs in Pregnancy and Lactation, is with the copyeditors and will be released in August 2014. The book will have about 125 new drugs and more than 200 revisions of ninth-edition drugs. No new data were found for more than 300 drugs, and about 160 drug reviews were removed because they were no longer on the market.

Lamis Karaoui, Pharm.D., BCPS

• American College of Clinical Pharmacy; O’Connell MB, Jackson AN, Karaoui LR, Rodriguez de Bittner M, Chen AM, Echeverri M, et al. Cultural competency in health care and its implications for pharmacy. Part 3A: emphasis on pharmacy education, curriculums, and future directions. Pharmacotherapy 2013;33:347-67.
• American College of Clinical Pharmacy; O’Connell MB, Jackson AN, Karaoui LR, Rodriguez de Bittner M, Chen AM, Echeverri M, et al. Cultural competency in health care and its implications for pharmacy. Part 3B: emphasis on pharmacy education policy, procedures, and climate. Pharmacotherapy 2013;33:e368-81.
• Chahine EB, Karaoui LR, Mansour H. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann Pharmacother 2014;48:107-15.

 

Promotion:

Karen Whalen, Pharm.D., BCPS, CDE: Promoted to an assistant dean for clinical education at the University of Florida.

 

Awards:

Christina M. Madison, Pharm.D., BCACP, AAHIVP: Received the American Pharmacists Association (APhA) Pharmacy Today One to One Counseling Award, Honorable Mention (March 2014) and the Southern Nevada Immunization & Health Coalition (SNIHC) Silver Syringe Award – 2013 Immunization Education Champion of the Year (awarded December 2013).

Nikki Milne, Pharm.D., BCPS: Received the Utah Society of Health-System Pharmacists (USHP) New Practitioner of the Year Award (2013–2014).

 

Publications:

Laura Borgelt, Pharm.D., FCCP, BCPS

• Anderson SL, Borgelt LM. Case report: risk of uterine perforation from IUDs is greatest during postpartum period. Am Fam Physician 2013;88:634-6.
• McBane SE, Borgelt LM, Barnes KN, Westberg SM, Lodise NM, Stassinos M. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the women’s health practice and research network of the American College of Clinical Pharmacy. Pharmacotherapy 2014 Jan 4. [Epub ahead of print]

Sarah McBane, Pharm.D., FCCP, BCPS, CDE

• McBane S, Borgelt L, Barnes K, Westberg S, Lodise N, Stassinos M. Use of Compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Article first published online: 2014 Jan 4 (doi: 10.1002/phar.1394).

Sally Rafie, Pharm.D., BCPS

• Jahansouz F, Rafie S, Chu F, Lamott J, Atayee R. Impact of smart infusion pump implementation on intravenous patient-controlled analgesia medication errors. Calif J Health Syst Pharm 2013;25:145-50.
• Rafie S, Kim GY, Lau LM, Tang C, Brown C, Maderas NM. Assessment of family planning services at community pharmacies in San Diego, California. Pharmacy 2013;1:153-9.

 

Other Notable Acheivements:

Laura Borgelt, Pharm.D., FCCP, BCPS: Passed the NCMP examination as an NAMS Certified Menopause Practitioner (NCMP).

Christina M. Madison, Pharm.D., BCACP, AAHIVP Credentialing: American Academy of HIV Medicine as an HIV Pharmacist (AAHIVP).